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ABSTRACT OF THE DISSERTATION
EPIGENETIC INSTABILITY INDUCED BY DNA BASE LESIONS VIA DNA BASE
EXCISION REPAIR
by
Zhongliang Jiang
Florida International University, 2017
Miami, Florida
Professor Yuan Liu, Major Professor
DNA damage can cause genome instability, which may lead to human cancer. The
most common form of DNA damage is DNA base damage, which is efficiently repaired
by DNA base excision repair (BER). Thus BER is the major DNA repair pathway that
maintains the stability of the genome. On the other hand, BER mediates DNA
demethylation that can occur on the promoter region of important tumor suppressor genes
such as Breast Cancer 1 (BRCA1) gene that is also involved in prevention and development
of cancer. In this study, employing cell-based and in vitro biochemical approaches along
with bisulfite DNA sequencing, we initially discovered that an oxidized nucleotide, 5’,2cyclo-2-deoxyadenosine in DNA duplex can either cause misinsertion by DNA polymerase
β (pol β) during pol β-mediated BER or inhibit lesion bypass of pol β resulting in DNA
strand breaks. We then explored how a T/G mismatch resulting from active DNA
demethylation can affect genome integrity during BER and found that pol β can extend the
mismatched T to cause mutation. We found that AP endonuclease 1 (APE1) can use its 3'5' exonuclease to remove the mismatched T before pol β can extend the nucleotide
preventing a C to T mutation. The results demonstrate that the 3'-5' exonuclease activity of
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APE1 can serve as a proofreader for pol β to prevent mutation. We further explored the
effects of exposure of environmental toxicants, bromate and chromate on the DNA
methylation pattern on the promoter region of BRCA1 gene with bisulfite DNA
sequencing. We found that bromate and chromate induced demethylation of 5methylcytosines (5mC) at the CpG sites as well as created additional methylation at several
unmethylated CpG sites at BRCA1 gene in human embryonic kidney (HEK) 293 cells. We
further demonstrated that the demethylation was mediated by pol β nucleotide misinsertion
and an interaction between pol β and DNA methyltransferase 1 (DNMT1) suggesting a
cross-talk between BER and DNA methyltransferases. We suggest that DNA base damage
and BER govern the interactions among the environment, the genome and epigenome,
modulating the stability of the genome and epigenome and disease development.
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INTRODUCTION
A. DNA DAMAGE CAUSED BY ENVIRONMENTAL TOXICANTS, BROMATE
AND CHROMATE
Deoxyribonucleic acid (DNA) is recognized as the “life code” which carries all the
genetic information of a cell in the form of genes, which are the blueprint that determines
all the protein sequences, structures, and the biological functions in a specific organism.
However, double-strand DNA in living cells constantly encounters endogenous and
exogenous DNA damaging agents (Hoeijmakers, 2001) . As a result, DNA lesions are
generated throughout every cell’s life cycle. It has been estimated that there are

	
  

	
  

Figure I.1 DNA damage and DNA repair pathways. The DNA lesions induced by the DNA
damaging agents are listed in the middle of Fig. I.1. DNA base lesions including uracil, abasic
site, 8-oxoguanine (8-oxoG), and single-strand DNA (ssDNA) breaks are repaired by DNA base
excision repair (BER). The bulky adducts, such as CPD (cyclobutane pyrimidine dimer) are
repaired through nucleotide-excision repair (NER). The interstrand cross-links, double strand
breaks are repaired through homologous recombination and nonhomologous end-joining (HR,
NHEJ). The A-G, T-G mismatches, insertion, deletion errors are repaired by mismatch repair
(Hoeijmakers, 2001).
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approximately 70,000 DNA lesions that are generated endogenously in a single human cell
per day under normal physiological conditions (Lindahl and Barnes, 2000). Among them
about 75% are single-strand DNA (ssDNA) breaks, which are produced through cell
metabolism or spontaneous base hydrolysis which disrupts the molecule (Tubbs and
Nussenzweig, 2017).
Another endogenous source of generating DNA damage is through replication and
repair DNA polymerases. Since the human genome contains approximately 3 billion base
pairs formed on the 23 chromosomes in the nucleus of each cell (Voet and Voet, 2011),
which means that about 6 × 109 nucleotides are synthesized by DNA polymerases during
DNA replication each time a cell divides. During DNA replication an error, can be made
by nucleotide misinsertions of DNA polymerases at a low rate. Thus, a high frequency of
cell divisions increases the probability of DNA replication errors by DNA polymerases
which means the total number of cell divisions in normal stem cells derived from a specific
type of tissue is usually used to assess the risk for cancer development in different tissues
(Tomasetti and Vogelstein, 2015). Moreover, specific loci and DNA sequences in the
genome also leads to susceptibility of DNA damage and mutations. For example, early
replicating fragile sites (ERCFSs) that occur at the origins of replication in mammalian
cells usually have highly expressed gene clusters enriched for repetitive sequences and
CpG dinucleotides (Barlow et al., 2013) compared with late replicating common fragile
sites (CFSs). These loci are hotspots of oncogene-induced DNA damage that preferentially
attack the fragile sites (Sarni and Kerem, 2016).
Gene transcription can also form a source of endogenous DNA damage and plays
a role in causing DNA damage and mutations. For example, transcription can induce the

2	
  

formation of an R-loop that in turn forms hotspots of endogenous DNA damage resulting
from ROS and activation-induced cytidine deaminase (AID) leading to high frequencies of
mutations and recombination (Tubbs and Nussenzweig, 2017). An increase in gene
transcription stimulates spontaneous mutations in yeast (Datta and Jinks-Robertson, 1995).
In mammalian cells, transcriptionally active gene loci bear more gene translocations and
are more fragile than less-active loci (Barlow et al., 2013; Chiarle et al., 2011; Klein et al.,
2011). A recent result from DNA sequencing of the genome of individual neurons in the
human prefrontal cortex has shown that each neuron has more than 1,000 mutations that
are induced by DNA damage in its own distinct genome (Lodato et al., 2015) which also
appears to be a result of highly active transcriptional activity in human neurons. The
mutations induced by DNA damage in neuron genomes further indicates that neuronal
genome are constantly exposed to endogenous and exogenous DNA damage leading to
mutations.
The exogenous DNA damaging sources include ionizing radiation, UV and a
variety of environmental toxicants and pollutants that can induce DNA base lesions and
DNA strand breaks. If not repaired, the damage can result in point mutations,
recombination, genome instability, cell death and ultimately development of diseases
including cancer and neurodegeneration. Early studies have shown that exposure to
environmental pollutants can significantly increase the risk of cancer development. One
well-known case is the high rate of skin carcinoma in chimney sweeps, which was first
described in 1775 by Percivall Pott (Waldron, 1983b), and the soot exposure was confirmed
as the cause of scrotal cancer in chimney sweeps (Waldron, 1983a). Another case was the
experiment done in 1912 by Bayon who injected coal-tar into rabbit ears (Bayon, 1912)
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which resulted in coal tar-induced cancer. Katsusaburo Yamagiwa and Koichi Ichikawa
repeated this experiment in 1915 by brushing coal-tar on to the ears of rabbits and also
successfully induced cancer (Fujiki, 2014). These studies raised the awareness in the public
that environmental pollutants play an important role in cancer development. Throughout
many years of research, now we understand that DNA damage result from the exposure to
both endogenous and exogenous sources plays a significant role in cancer development.
The environmental pollutant, potassium bromate (KBrO3) had been a widely used
as a food additive that was mainly added to flour as maturing agent to improve its texture
in the bread-making process. Bromate was also widely used in beer malting and cheese
making (Ahmad et al., 2014). However, later it was found that oral administration of
bromate for 104 weeks induced renal cell tumor in F344 rats (Kurokawa et al., 1986) and
was prohibited from being used as a food additive (IARC 1999). Nevertheless, bromate is
currently still used in cold-wave hair lotions and textile dyeing with sulfur dyes (Ahmad et
al., 2012; Ajarem et al., 2016; Khan et al., 2004; Kurokawa et al., 1986). Furthermore,
because of the use of ozonation of drinking water, bromate has been generated as one of
the major water disinfection byproducts (Campbell, 2006; Cavanagh, 1992; Dongmei et
al., 2015). In vivo studies have shown that expose of human cell lines (HL-60 cells, HP100
cells) to bromate can significantly increased the cellular level of 8-oxo-7,8-dihydro-2’deoxyguanine (8-oxoG) in comparison with the non-treated cells (Murata et al., 2001).
Employing an in vitro experiment, the Murata group found that bromate did not induce
alkylated DNA bases or DNA backbone breakage (Figure I.2A). Instead, bromate directly
induced the formation of an 8-oxoG, which can be removed by formamidopyrimidineDNA glycosylase (FPG) (Figure I.2B). Since FPG can specifically remove an 8-oxoG, the
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results along with the previous results all indicate that bromate can induce the production
of 8-oxoGs in living cells. A possible mechanism by which bromate generates 8-oxoGs in
cells have been proposed and demonstrated in Figure I.3.

	
  

	
  
	
  
Figure I.2 FPG removes the DNA damage induced by KBrO3. DNA was treated with hot
piperidine (A) or Fpg protein (B). Data are taken from (Murata et al., 2001)
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Figure I.3 A possible mechanism of guanine oxidation induced by KBrO3 in the presence
of glutathione/cystein (Kawanishi and Murata, 2006).

As is shown in Figure I.3, guanine is the hotspot for bromate to generate the most
prevalent DNA damage, 8-oxoGs. It was estimated that under physiological conditions,
more than 10,000 8-oxoGs can be generated per cell per day. 8-oxoGs can be generated at
a guanine at any location in the genome, and they can base pair with adenine through
Hoogsteen base pair that results in mismatched base pairs and point mutations (Figure I.4)
(David et al., 2007). Thus, mutations created by an 8-oxoG can happen at any site of any

genes in the human genome.
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Figure I.4 8-oxoG base pairs with C and A (David et al., 2007)
	
  

Chromium (Cr) VI and its compounds including chromate. have been used in
manufacturing of stainless steel and pressure-treated wood for years. About half a million
industrial workers in the US and other countries undergo occupational exposure to Cr (VI)
(Occupational and Health Administration, 2006). Chromium VI is a potent carcinogen and
mutagen. The oxidation state of chromium has been found to be the key factor that
determines the carcinogenicity and mutagenicity of various Cr (VI) compounds (Jennette,
1979). Under neutral pH, Cr (VI) exists as a mixture of chromate (CrO42-) or
hydrochromate (HCrO4-) anions with the ratio around 3:1 (Zhitkovich, 2005). Chromium
VI enters human cells readily through the sulfate channels (Alexander and Aaseth, 1995).
In cells Cr (VI) can be reduced to Cr (III), the final oxidized form of Cr found in all
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biological systems which is thermodynamically stable. Animal studies have shown that all
Cr (IV) compounds including calcium chromate, potassium chromate, lead chromate,
chromic chromate, and strontium chromate, can result in sarcomas (spindle cell carcinomas
and fibrosarcomas) in animals (Jennette, 1979). In contrast, Cr (III) compounds are not
mutagenic. When Cr (VI) is reduced to Cr (III) extracellularly, it is usually considered as
a detoxification Cr (VI) because of the poor cellular permeability of Cr (III) compounds.
However, when Cr (VI) reduction occurs inside cells, it can exhibit genotoxicity (Salnikow
and Zhitkovich, 2008). It has been shown that ascorbate is the main reducer of Cr (VI) in
cells, particularly in cells that contain abundant ascorbate such as human lung cells (1.3
mM). In cells with a low level of ascorbate such as human nonhepatic cells, thiols are
responsible for reducing Cr (VI) (Zhitkovich, 2005). Although various amounts of Cr (V),
Cr (IV) and organic chromium radicals can be generated during the Cr (VI) reduction
process (Stearns and Wetterhahn, 1994), the end-product of its metabolism is always Cr
(III), which forms complexes with proteins and nucleic acids.
The DNA damage generated during Cr (VI) reduction includes Cr-DNA adducts,
DNA-protein crosslinks, DNA interstrand crosslinks, DNA breaks, and DNA base damage
(Salnikow and Zhitkovich, 2008). Adducts of the Cr-DNA are the most abundant form of
DNA lesions. They are induced by Cr (VI) reduction mediated by cysteine and ascorbate
in mammalian cells (Figure I.5) (Salnikow and Zhitkovich, 2008). The reduction products
include glutathione-Cr-DNA, cysteine-Cr-DNA, histidine-Cr-DNA and ascorbate-CrDNA complexes (Quievryn et al., 2002; Voitkun et al., 1994; Zhitkovich et al., 1995). It
has been shown that acorbate-Cr-DNA crosslinks are the major pre-mutagenic Cr-DNA
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modifications (Quievryn et al., 2003; Voitkun et al., 1998). Chromate causes elevation of

	
  

	
  

Figure I.5 Major steps in uptake, metabolism and formation of DNA damage by Cr (VI)
(Salnikow and Zhitkovich, 2008)	
  

NADPH oxidase activity and mitochondrial damage, which can ultimately lead to an
increase of H2O2 level (Salnikow and Zhitkovich, 2008). In addition, it can result in the
single-strand DNA (ssDNA) breaks in cells of animal tissues (Gao et al., 1992; Hodges et
al., 2001; Sugiyama et al., 1986; Ueno et al., 2001). The generation of ssDNA breaks has
been shown to be caused by oxidizing free radicals generated during the reactions between
Cr (V) and H2O2 (Messer et al., 2006).
Since Cr (VI) can lead to an increase of H2O2 level and oxidative stress in cells,
which can further cause additional severe biological consequences. Chromium VI can
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damage a variety of cellular components including proteins, lipids, DNAs and RNAs. Cr
(VI)-induced oxidative DNA damage plays critical roles in causing genome instability and
carcinogenesis (Kawanishi et al., 2002; Kawanishi et al., 2001). Earlier studies showed that
chromate exposure can induce both ssDNA breaks and abasic sites (Casadevall and
Kortenkamp, 1994, 1995). Although there is no direct evidence showing that chromate
exposure can induce 8-oxoG, the indicator of oxidative damage on DNA, Slade et al. have
reported that ascorbate-mediated Cr (VI) reduction yields significant amount of
spirominodihydantoin, which is a guanine oxidation product (Slade et al., 2005) indicating
that chromate can also attack guanine in DNA.
Taken together, both bromate and chromate exposure can cause severe oxidative
DNA damage in the genome by attacking guanines in the DNA, in particular the guanines
located at G rich regions such as CpG islands in the promoter region of genes as well as
the regions containing trinucleotide repeats, which are the hotspots of DNA damage
induced by bromate and chromate. If the mutations remain in the genome, they can further
modulate genome and epigenome stability.

Thus, understanding how bromate and

chromate exposure can alter modulate genome and epigenome stability is important for us
to further explore the etiology, prevention and diagnosis of environmentally-induced
cancer.
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B. BASE EXCISION REPAIR IS THE MAJOR PATHWAY TO REPAIR
OXIDATIVE DNA DAMAGE AND PLAYS A CRITICAL ROLE IN ACTIVE
DEMETHYLATION IN CpG DINUCLEOTIDE CLUSTERS.
As summarized in the previous section, the unrepaired DNA damage can cause
DNA base lesions, strand breaks, distortion of the double helix structure of DNA,
ultimately mutations which can alter the expression of tumor suppressors or oncogenes
promoting cell proliferation which will result in cancer development. In mammalian cells,
different types of DNA damage are repaired thorough different DNA repair pathways as
summarized in Figure I.1. The pathway that removes oxidative DNA damage including
DNA base lesions and single-strand DNA breaks, which are the most common form of
DNA damage, is the DNA base excision repair (BER) pathway (Neeley and Essigmann,
2006). The BER pathway was discovered more than thirty years ago, when Thomas
Lindahl searched for enzymes that repair an uracil, which is the product of cytosine
deamination. Later the enzyme that removes the lesion, uracil DNA glycosylase was
discovered (Friedberg and Lindahl, 2004). The enzyme recognizes and removes the uracil
which initiates the first step of the BER pathway (Barnes and Lindahl, 2004; David and
Williams, 1998; Fromme and Verdine, 2004). There are 2 subpathways of BER that have
been discovered, the short-patch BER (SP-BER, also known as single-nucleotide BER,
(SN-BER) and long-patch BER (LP-BER) (Figure I-6). The difference between the two
subpathways falls into the number of the nucleotides synthesized and replaced during the
repair, as well as the repair enzymes and cofactors that participate in the repair process
(Biade et al., 1998b; Fortini et al., 1998; Frosina et al., 1996; Klungland and Lindahl, 1997;
Liu and Wilson, 2012). The enzymes that initiate the BER pathway are called DNA
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glycosylases (Fromme and Verdine, 2004). These enzymes catalyze the cleavage of the
glycosidic bond that link a damaged base with a deoxyribose, thereby removing the base
lesion from the DNA backbone (Fromme and Verdine, 2004). In human cells, different
DNA glycosylases exhibit their specific activity to different types of base lesions (Brooks
et al., 2013; Fromme et al., 2004; Sampath et al., 2012; Wallace, 2014). Uracil DNA
glycosylase (UDG) that specifically removes an uracil. 8-oxoG DNA glycosylase 1

Figure I.6 Pathways of DNA Base Excision Repair (Liu and Wilson, 2012)
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(OGG1) specifically removes an 8-oxoG, and 3-alkyladenine DNA glycosylase (AAG)
preferentially

Figure I.7 The dRP lyase mechanism of pol β (Stevens et al., 2013)

remove an alkylated base such as 3-methyl-A. Removal of a base lesion will leave an abasic
site (AP site), which is then recognized by AP endonuclease 1 (APE1). Subsequently,
APE1 incises the AP site at the 5’-side of the site resulting in the formation of a onenucleotide gap with an 3’-hydroxyl in the upstream, and a 5’-dRP in the downstream (Liu
and Wilson, 2012; Masuda et al., 1998; Wilson et al., 1995). Then the oxidation of the
sugar on the 5’-dRP group determines which BER subpathway the lesion follows. If the
5’-dRP group is unmodified and remains as a native sugar, pol β dRP lyase directly
removes the group with its dRP lyase activity (Stevens et al., 2013) through β-elimination
(Figure I.7) that involves the formation of a Schiff base and formation of a temporary pol
β-DNA crosslink intermediate. The pol β polymerase activity then synthesizes one
nucleotide to fill in the gap generating a nick, which is then sealed by DNA Ligase I (LIG
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I) or DNA Ligase III (LIG III)-X-ray cross-complementing group 1 (XRCC1) complex. In
above subpathway, the repair is accomplished with replacement of one nucleotide, i.e. SNBER or SP-BER.
However, if the 5’-dRP sugar is further oxidized by oxidative stress, pol β dRP
lyase activity cannot remove the sugar. The repair of the lesion must be subject to LP-BER
where pol b fills the gap by synthesizing two or two more nucleotides. A 5'-sugar phosphate
is then recognized and removed by flap endonuclease 1 (FEN1) (Figure I.6, subpathway
2a and 2b) (Frosina et al., 1996; Liu and Wilson, 2012). There are two subpathways for
LP-BER, the “Hit and Run” subpathway and the “strand displacement synthesis”
subpathway that fulfill the process of base lesion repair (Figure I.6). In the “Hit and Run”
subpathway, APE1 incises an abasic site leaving a 1 nt gap with a 5' modified sugar residue.
One nucleotide is inserted by pol β to fill the gap creating a sugar flap attached to a
downstream nucleotide. Subsequently, FEN1 captures the dRP flap by cleaving the
downstream nucleotide that is attached to the modified sugar, leaving an additional 1 nt
gap. The pol β capture fill the gap, leaving a nick which is then sealed by LIG I. In the
demonstrated subpathway, only two nt are replaced (Liu and Wilson, 2012). In another
subpathway of LP-BER, three or more nucleotides are synthesized and replaced via the
“strand displacement synthesis” that can be mediated by either pol b or replication DNA
polymerases, DNA polymerase δ (pol δ) or DNA polymerase ε (pol ε). In this subpathway,
after APE1 incision of an abasic site, pol β and/or pol δ or pol ε perform strand
displacement synthesis by inserting 3 or more nucleotides to elongate the upstream strand.
As a result, the downstream strand is displaced, resulting a 5’-flap (Dianov et al., 1999;
Klungland and Lindahl, 1997; Parikh et al., 1998; Podlutsky et al., 2001). Flap
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endonuclease 1 (FEN1) can then capture the flap and be loaded flap through threading
through the free 5’-end of the flap and track down to the base of the flap where it makes
cleavage of the flap, thereby removing the modified sugar (Harrington and Lieber, 1994;
Murante et al., 1995; Prasad et al., 2000). The above process results in a nick that is sealed
by LIG I completing LP-BER (Liu and Wilson, 2012). The efficiency of the LP-BER
subpathways is also modulated by the coordination among BER enzymes and cofactors.

	
  
Figure I.8 Cytosine methylation and pathways of active DNA demethylation (Bacolla et al.,
2014)

BER also plays essential role in mediating the active demethylation of 5’methylcytosines (5mCs). Active DNA demethylation regulates DNA methylation pattern
in gene promoters and protein encoding regions, which plays critical roles in many
biological processes including regulation of gene expression, retrovirus silencing, X
chromosome inactivation among others (Ito and Kuraoka, 2015; Smith and Meissner,
2013). The pattern of DNA methylation, determined by the combination of methylation at
the 5-position of a cytosine (5mC) and its demethylation at CpG clusters and islands in
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gene promoters, governs gene expression by regulating chromatin structures and
accessibility of transcription factors to the promoter regions. If a CpG island in a promoter
region is hypomethylated, i.e., a low level of 5mCs, chromatin adopts an open
configuration, allowing transcriptional factors to access the promoter regions to initiate
gene transcription. If a CpG island is hypermethylated, i.e., a high level of 5mCs,
methylated Cs will attract methylC binding proteins (MBDs) to bind to the promoter
region. The binding of MBDs to the promoter subsequently recruits histones that bear
posttranslational modifications for a closed chromatin configuration, thereby preventing
the binding of transcription factors to the DNA and inhibiting transcription initiation and
silencing gene expression. Thus, hypermethylated CpG islands can serve as a “switch off”
mark of a specific gene. By participating in the demethylation of 5mCs in the CpG islands,
BER can modulate gene expression in embryonic and somatic cells (Bellacosa and Drohat,
2015; Drohat and Coey, 2016b; Fleming et al., 2017; Furlan et al., 2017; Li et al., 2013;
Seisenberger et al., 2013).
The first step of the BER-mediated active demethylation is the oxidation of 5’methylcytosine that is catalyzed by the Ten-Elven Translocation (TET) oxidases during
which 5mCs are converted to 5’-hydroxycytosines (5hmCs) (Figure I-8). Subsequently, an
enzyme, AID/apolipoprotein B editing complex (APOBEC) protein, converts a 5hmC to a
5-hydroxymethyluracil (5hmU), which is recognized by the DNA glycosylase, singlestrand-selective monofunctional uracil-DNA glycosylase I (SMUG1). Furthermore, a 5mC
can also be spontaneously deaminated into thymine, which can be recognized and removed
by thymine DNA glycosylase (TDG). The oxygenases, TET 1, 2 and 3 enzymes can oxidize
5hmC into 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) (Figure I.8). Figure I-9
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illustrates the mechanisms by which TETs convert 5mC to 5hmC, 5fC, and 5caC (Bochtler
et al., 2017). The 5fC and 5caC base lesions that base pair with a guanine can also be
recognized and removed by TDG (Bellacosa and Drohat, 2015; Drohat and Coey, 2016a;
Gong and Zhu, 2011; Ito and Kuraoka, 2015; Mahfoudhi et al., 2016; Maiti and Drohat,
2011; Niehrs and Schafer, 2012; Wallace, 2014). Thus, the active DNA demethylation is
mediated by enzymatic conversion of 5mCs into a series of modified cytosines that are
recognized as DNA base lesions by DNA glycosylases. Removal of the DNA base lesions
initiate the BER pathway that efficiently repairs the lesions generated from 5mCs. Through
BER, a 5mC is replaced by an unmodified cytosine, thus resulting in the completion of
active DNA demethylation (Wallace, 2014) that modulates gene expression.

Figure I.9 TET-catalyzed oxidation reactions. A) Incorporation of an oxygen molecule into
5mC, 5hmC, and 5fC. B) Activation of molecular oxygen and formation of the Fe(IV)=O
intermediate (Bochtler et al., 2017).
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MODULATING ACTIVITIES OF DNA METHYLTRANSFERASES (DNMTs).
During DNA replication, mammalian cells, both genetic and epigenetic information
including DNA methylation, chromatin structure and histone modifications, must be
replicated (Mortusewicz et al., 2005). Methylation of a cytosine in the CpG islands is
catalyzed by DNA methyltransferases (DNMTs), which transfer a methyl group from the
methyl donor, S-adenosyl-L-methionine (SAM) to the 5-position of the cytosine in DNA
(Robertson, 2005). The DNMTs family has four members including DNA
methyltransferase 1 (DNMT1), DNMT3a, DNMT3b, and DNMT3L. Since DNMT3L does
not exhibit any enzymatic activity in cells (Kareta et al., 2006), the mammalian DNA
methylation is carried out by three DNA methyltransferases, DNMT1, DNMT3a, and
DNMT3b.The compounds DNMT3a and 3b can methylate a cytosine on CpG islands and
are called de novo DNMTs. However, DNMT1 recognizes a hemi-methylated DNA strand
as the substrate. Thus, it methylates cytosines at the newly synthesized DNA strand by
recognizing a 5mC in the parental strand after DNA replication. As a result, DNMT1
sustains an established DNA methylation pattern (Chuang et al., 1997; Leonhardt et al.,
1992). Thus, DNMT1 is called a maintenance DNA methyltransferase. Several studies also
have shown that there is functional overlap between the de novo and maintenance
methyltransferases (Egger et al., 2006; Riggs and Xiong, 2004), This indicates that
DNMT1 may play more complicated roles in modulating methylation pattern than thought
before. Previous studies showed that knockout of DNMT1 or DNMT3b resulted in
embryonic lethality in mice, indicating the critical role of DNA methylation during
embryonic development. Previous studies have also found that the mutations of DNMTs
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caused genetic disorders (Li et al., 1992; Okano et al., 1999). Furthermore, disruption of a
normal DNA methylation pattern such as the hypermethylation in the promoters of tumor
suppressor genes and the global hypomethylation, is commonly detected in cancer cells
(Jones and Baylin, 2002) indicating its association with cancer development. Because
CpGs are composed of Cs and Gs that can be readily deaminated enzymatically and
spontaneously as well as oxidized by endogenous and exogenous oxidative DNA damage,
they can readily form hotspots of DNA base damage that can be repaired by BER. Recent
studies have shown that DNMTs can cooperate with each other to efficiently methylate
repetitive elements in the genome to prevent the expression of these elements in cells
(Subramaniam et al., 2014). Moreover, earlier studies also show that DNMT1 helps restore
the epigenetic information during DNA repair by interacting with a DNA repair cofactor,
proliferating cell nuclear antigen (PCNA) (Mortusewicz et al., 2005). By interacting with
PCNA through its PCNA binding domain, DNMT1 can be recruited to double strand DNA
breaks (DSBs) (Chuang et al., 1997; Leonhardt et al., 1992; Mortusewicz et al., 2005). The
recruitment of DNMT1 to DSBs is also mediated through the interaction between DNMT1
and Rad 9, which is a component of the Rad 9-Hus 1-Rad 1 sliding clamp (Ha et al., 2011).
Furthermore, during DSB break repair mediated by homologous recombination (HR),
DNMT1 can interact with the growth arrest and DNA-damage-inducible protein α
(GADD45α) protein to precisely select the DNA strand that needs to be methylated (Lee
et al., 2012). This suggests that DNMTs can modulate DNA repair by coordinating with
DNA repair enzymes and cofactors. Since BER is the pathway to repair the small DNA
lesions such as 8-oxoG as well as the modified DNA bases generated by active DNA
demethylation, i.e., 5hmC, 5fC, and 5caC, it is possible that DNMT1 may also interact with
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BER enzymes such as pol β during BER and/or active demethylation process. In this
scenario, BER and DNMTs may crosstalk with each other on the sites with modified or
damaged DNA bases to ensure the efficiency of damage repair as well as maintenance of
integrity of DNA methylation and demethylation.
D. BREAST CANCER 1 (BRCA1) PLAYS A CRITICAL ROLE IN PREVENTING
THE DEVELOPMENT OF BREAST CANCER.
Breast cancer is one of the most common invasive cancers in women and the leading cause
of cancer death in women under 40 years old (Alabdulkareem et al., 2017). It has been
found that development of breast cancer is associated with the breast cancer 1 gene
(BRCA1), which is located at the 17th chromosome in human genome (Figure I-10). The
BRCA1 protein is a 1863 amino acid protein and functions as a tumor suppressor
(Henderson, 2012). The problem is involved in DNA repair regulation, genome
maintenance, cell survival, and apoptosis (Clark et al., 2012; Henderson, 2012; Long and
Walter, 2012) and directly participates in repair of DSBs caused by endogenous and
exogenous DNA damaging agents by interacting with other DNA repair proteins
(Cousineau et al., 2005; Hu et al., 1999; Huen et al., 2010; Kote-Jarai and Eeles, 1999; Liu

Figure I.10 BRCA1 gene is located on the 17th chromosome in human genome
(NIH U.S. National Library of Medicine BRCA1).
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et al., 2007a; Moynahan et al., 1999). For example, BRCA1 can interact with BRCA2 to
promote efficient and precise repair of DSBs resulting in maintenance of genomic stability.
During DSB repair, BRCA1 is recruited to DSB sites. This is mediated by ubiquitination
of histone H2A and H2B. Initially DSBs induces the phosphorylation of the histone protein,
H2AX on the DNA damage via ATM and ATR (Burma et al., 2001). Subsequently, an E3
ubiquitin ligase RNF8 and a phosphor-module binding mediator MDC1 are recruited to
DSB sites (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 2007; Stucki et al., 2005).
RNF8 then interacts with the E3 ubiquitin conjugase UBC14 to ubiquitinate histone H2A
and H2B at the lesions in the chromatin. This then recruits BRCA1 to the DNA damage
sites (Wu et al., 2009; Zhao et al., 2007). BRCA1 then recruits RAD51 to DSB sites
mediating DNA strand branch migration during DSB repair via HR (Scully et al., 1997).
BRCA1 also interacts with other DNA repair machineries and recruits them to the DNA
damage sites. These include RAP80, CCDC98/Abraxas, NBA1/MERIT40, BRCC36 and
BRCC45 (Feng et al., 2009; Kim et al., 2007; Liu et al., 2007c; Shao et al., 2009; Sobhian
et al., 2007; Wang et al., 2009; Wang et al., 2007). The formation of the complex between
these proteins and BRCA1 is mediated by a series of sequential steps starting from
ubiquitination of histones at the sites of DNA damage. This is recognized by RAP80
leading to the formation of a BRCA1-RAP80 protein complex. Moreover, BRCA1 is also
involved in the activation of cell cycle check point induced by DSBs to initiate cell cycle
arrest. This allows cells to have sufficient time to repair the DNA damage (Hartwell and
Kastan, 1994), thereby preventing the duplication of damaged DNA and passage of the
damaged DNA to daughter cells. BRCA1 is involved in the activation of all the cell
checkpoints including G1/S, S-phase, and G2/M checkpoints. BRCA1 can act as a scaffold
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protein to facilitate ATM-mediated p53 phosphorylation resulting in activation of p21 that
eventually induces G1/S arrest (Fabbro et al., 2004). BRCA1 can participate in S-phase
checkpoint initiation along with ATM and Nbs1 (Xu et al., 2001). Its roles in inducing the
G2/M checkpoint have been most intensively studied. DNA damage can activate PI3kinase-like kinase (PI3KK), ATM and ATR (Greenberg et al., 2006). This subsequently
activates a series of protein kinases that regulate cell-cycle checkpoints. For example,
PI3KK, ATM, and ATR phosphorylate Chk1 on serine 317 and serine 345 (Cousineau et
al., 2005; Xu et al., 2001; Zhao et al., 2002). This further activates Wee1 (Greenberg et al.,
2006; O'Connell et al., 2000), which can then inactivates Cdc25 that dephosphorylates
Thr14 and Thr15 of Cdc2. The inactivation of Cdc25 sustains the phosphorylated Thr14
and Thr15 of Cdc2 (Perry and Kornbluth, 2007; Yarden et al., 2002), thereby activating
G2/M checkpoint. In addition, BRCA1 can cooperate with the reactive attachment disorder
3-reactive attachment disorder 26 (Rad3-Rad26) complex to cause the phosphorylation of
Ser317 and Ser345 on Chk1 that activates G2/M checkpoint. BRCA1 is also involved in
DNA damage-induced activation of ATM and ATR (Greenberg et al., 2006). Furthermore,
BRCA1 can cooperate with BRCA1-C-terminus-domain containing proteins (BRCTs),
checkpoint loading complex (CLC), and checkpoint sliding clamp (CSC) to activate G2/M
checkpoint (O'Connell et al., 2000). Also it has been shown that the phosphorylation of
BRCA1 at serine1423 by ATM is implicated to be important for activation of IR-induced
G2/M checkpoint (Xu et al., 2001). Thus, BRCA1 plays multifaceted roles in maintaining
genome stability by facilitating DSB repair and regulating the check points cell cycle.
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OVERVIEW
Cellular DNA is frequently damaged by endogenous and exogenous DNA
damaging agents. It has been estimated that more than 10,000 base lesions are generated
per cell per day. These lesions are efficiently repaired by the BER pathway. However, a
base lesion with a covalent bond formed between the C5 of a deoxyribose and C8 of a
purine such as 5’,8-cyclopurine-2’-deoxynucleoside (cdPu) can be only repaired by NER
with a low efficiency readily accumulating in the genome. Accumulated cdPu lesions can
effectively block replication DNA polymerases, and have to be bypassed by lesion bypass
synthesis via repair DNA polymerases for cell survival. Yet, the mechanisms by which
cdPu lesions are bypassed remain to be elucidated. On the other hand, DNA bases are
chemically modified at CpG clusters and islands located at gene promoters and protein
encoding regions, and this serves as an essential step to initiate and regulate cellular
epigenetic features through DNA methylation and demethylation mediated by BER for
regulation of gene expression. However, CpGs can also form hotspots of DNA base
damage such as uracils and thymines from deamination of Cs and 5mCs as well as 8-oxoGs.
Thus, cellular DNA methylation and demethylation frequently converges with DNA base
damage and repair. It appears that BER evolves as a central component in mediating the
interplay between epigenetics and DNA damage and repair as a part of genome and
epigenome interaction which can be further modulated by environmental toxicants such as
bromate and chromate that can oxidize DNA bases. The DNA damage induced by the
environmental toxicants may further alter DNA methylation pattern on the promoter
regions of tumor suppressor genes, leading to cancer development. In CHARPTER 1,
employing pol β wild-type (WT) and pol β knockout (KD) mouse embryonic fibroblast
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(MEF) cell extracts, we provided the first evidence showing that pol β plays a critical role
in bypassing a R’-cdA lesion efficiently. We further demonstrated that pol β performed
nucleotide misinsertion in bypassing a R’-cdA indicating a pol b-mediated mutagenic
effect during its lesion bypass synthesis. In CHARPTER 2, we further examined the effects
of an abasic lesion next to a DNA demethylation intermediate, the T/G mismatch in a CpG
dinucleotide on the activity of major BER enzymes and the integrity of CpGs. We showed
that pol b extended a mismatched T generated by DNA demethylation resulting in a C to
T mutation. However, we found that the mismatched T was efficiently removed by APE1
3’-5’ exonuclease activity, which prevented pol b-mediated mutations during BER and
active DNA demethylation. In CHARPTER 3, we further explored the effects of
environmental toxicants, bromate and chromate on the DNA methylation pattern of the
human tumor suppressor, BRCA1 gene. We showed that oxidative DNA damage induced
by bromate and chromate altered DNA methylation pattern by inducing additional DNA
methylation sites, loss of DNA bases and point mutations in the promoter region of BRCA1
gene and encoding region of BRCA1 protein. Moreover, we provided the first evidence
showing that DNMT1 was recruited to the DNA damage sites through the interaction with
pol β, thereby resulting in additional DNA methylation sites.
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CHAPTER 1
BYPASS OF A 5’,8-CYCLOPURINE-2’DEOXYNUCLEOSIDE BY DNA
POLYMERASE β DURING REPLICATION AND BASE EXCISION REPAIR LEADS
TO NUCLEOTIDE MISINSERTIONS AND DNA STRAND BREAKS

ABSTRACT
The DNA lesion 5’,8-cyclopurine-2’-deoxynucleosides including 5’,8-cyclo-dA
(cdA) and 5’,8-cyclo-dG (cdG) are induced by hydroxyl radicals resulting from oxidative
stress such as ionizing radiation. 5’,8-cyclopurine-2’-deoxynucleoside lesions are repaired
by nucleotide excision repair with low efficiency, thereby leading to their accumulation in
the human genome and lesion bypass by DNA polymerases during DNA replication and
base excision repair (BER). The present study, for the first time, we discovered that DNA
polymerase β (pol β) efficiently bypassed a 5’R-cdA, but inefficiently bypassed a 5’S-cdA
during DNA replication and BER. We found that cell extracts from pol β wild-type mouse
embryonic fibroblasts exhibited significant DNA synthesis activity in bypassing a cdA
lesion located in replication and BER intermediates. However, pol β knock-out cell extracts
exhibited little DNA synthesis to bypass the lesion which indicates that pol β plays an
important role in bypassing a cdA lesion during DNA replication and BER. Furthermore,
we demonstrated that pol β inserted both a correct and incorrect nucleotide to bypass a cdA
at a low concentration. Nucleotide misinsertion was significantly stimulated by a high
concentration of pol b, indicating a mutagenic effect induced by pol β lesion bypass
synthesis of a 5’,8-cyclopurine-2’-deoxynucleoside. Moreover, we found that bypass of a
5’S-cdA by pol β generated an intermediate that failed to be extended by pol b, resulting
in accumulation of single-strand DNA breaks. Our study provides the first evidence that
pol β plays an important role in bypassing a 5’,8-cyclo-dA during DNA replication and
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repair, as well as new insight into mutagenic effects and genome instability resulting from
pol β bypassing of a cdA lesion.
Keywords: 5’,8-cyclopurine-2’-deoxynucleoside, DNA polymerase β, Lesion bypass
synthesis, Base excision repair, DNA replication, Mutagenesis

1. INTRODUCTION
Reactive oxygen species (ROS) induced by endogenous oxidative stress and
environmental factors such as ionizing radiation can attack genomic DNA and result in
various types of DNA damage such as oxidized DNA base lesions, strand breaks and DNAprotein cross-links in the human genome (Cadet et al., 1999; Dizdaroglu et al., 2001b).
Because of its high reactivity with DNA bases, the hydroxyl radical (●OH) leads to the
formation of the majority of oxidized base lesions (Cadet et al., 2003). One type of oxidized
DNA base lesion induced by ●OH is the 5’,8-cyclopurine-2’-deoxynucleosides (cdPu),
which includes 5’,8-cyclo-2’-deoxyadenosine (cdA) and 5’,8-cyclo-2’-deoxyguanosine
(cdG). These lesions can exist in a 5’R or 5’S configuration. It has been found that both
configurations of cdPu lesions including 5’R-cdA and 5’S-cdA lesions can form naturally
in the genomic DNA of mammals (Chatgilialoglu et al., 2011b; Jaruga and Dizdaroglu,
2008; Mitra et al., 2012; Randerath et al., 2001; Shaked et al., 2012; Tilstra et al., 2012;
Zhang et al., 2013). Because cdPu lesions caused by the highly reactive free radical, ●OH,
which can be generated in cells by both endogenous and exogenous sources such as
ionizing radiation and carcinogens, cdPu lesions have been also proposed to be used as an
oxidative DNA damage marker to evaluate the level of oxidative stress in mammals
(Chatgilialoglu et al., 2011b; Jaruga and Dizdaroglu, 2008; Wang, 2008). Previous studies
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have shown that 180-320 cdPus/cell can be produced in fetal and postnatal rat liver per day
(Randerath et al., 2001). In addition, it has been estimated that cdA lesions occur at a
frequency of one lesion/107 DNA bases (Dizdaroglu et al., 2001a). In vitro studies have
shown that the ratio of the amount of 5’R-cdA to 5’S-cdA in DNA is about 3:1
(Chatgilialoglu et al., 2011b), suggesting a different efficiency in production of various
forms of cyclopurine lesions. The cdPus contain an extra covalent bond that links the C5’
of the 2'-deoxyribose and C8 of the purine in addition to the glycosidic bond. The extra
covalent bond can alter DNA structure (Chatgilialoglu et al., 2011a), thereby stabilizing
the glycosidic bond of the lesions (Das et al., 2012; Kamakura et al., 2012; Lindahl and
Wood, 1999) and preventing the cleavage of the bond by a DNA glycosylase (Das et al.,
2012; Kamakura et al., 2012; Lindahl and Wood, 1999). Because 5’,8-cyclopurine-2’deoxynucleoside lesions can induce distortions to double-stranded DNA that can be
recognized by nucleotide excision repair (NER) proteins, NER is the only repair pathway
that can remove this type of DNA damage (Brooks et al., 2000; Kropachev et al., 2014;
Kuraoka et al., 2000). However, the efficiency of removal of a 5’R- and 5’S-cdA lesion by
NER is two- to four-fold less than that for other bulky DNA adducts such as a cis-B[α]PN2-dG adduct (Kropachev et al., 2014). The low efficiency of repairing cdPus results in
the accumulation of a high level of cdPus in the genome which is supported by previous
studies showing that a significant amount of cdPu lesions were detected in genomic DNA
of cells and tissues of mammals and other organisms (Chatgilialoglu et al., 2011b;
Dizdaroglu et al., 2001a; Jaruga and Dizdaroglu, 2008). The cdPus can severely impair
normal cellular functions such as DNA replication and transcription (Yuan et al., 2011). It
has been shown that both 5’R-cdA and 5’S-cdA can directly block RNA polymerase II
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synthesis by inhibiting recruitment of RNA polymerase II to a promoter region (Brooks et
al., 2000; Marietta et al., 2002). The cdPus can also completely block DNA synthesis of
human replication polymerases such as pol δ, causing replication fork stalling (Kuraoka et
al., 2000). To resolve the stalled replication fork and restart DNA replication, Y family
DNA translesion polymerases are recruited to perform translesion synthesis to bypass the
base lesions (Friedberg et al., 2005). However, a template 5’S-cdA can also block lesion
bypass synthesis by Y family polymerases such as pol η and pol ι, resulting in accumulation
of DNA strand breaks and apoptosis (Kuraoka et al., 2001; Pednekar et al., 2014; You et
al., 2013). Furthermore, the lesion bypass of a cdA by Y family polymerases is highly
mutagenic (You et al., 2013). Thus, unrepaired cdPus in the genome may lead to adverse
biological effects, resulting in the development of human diseases and pathological
conditions such as cancer, neurodegeneration, and aging (Brooks, 2008; Jaruga and
Dizdaroglu, 2008; Kirkali et al., 2009; Wang et al., 2012; Wang et al., 2011).
DNA polymerase β (pol β) is the smallest DNA polymerase identified in cells thus
far (Beard and Wilson, 2014). It belongs to the X family of DNA polymerases (Braithwaite
and Ito, 1993). Pol β is composed of two subdomains, a 31 kDa polymerase domain and
an 8 kDa deoxyribose phosphate (dRP) lyase domain (Beard and Wilson, 2006). Pol β
plays an essential role in filling gaps and removing a 5’-dRP group during BER (Beard and
Wilson, 2006, 2014). Similar to the Y family translesion synthesis polymerases, pol β can
also perform translesion synthesis to bypass a DNA base lesion during replication and BER
(Bassett et al., 2002a; Batra et al., 2006; Beard et al., 2009; Chary et al., 2012a; Efrati et
al., 1997; Hashim et al., 1997b; Hoffmann et al., 1996b; Maga et al., 2009b; Servant et al.,
2002b; Vaisman and Chaney, 2000b; Villani et al., 2011b). Previous studies have shown
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that pol β can bypass small base lesions including 8-oxoG and apurinic/apyrimidinic sites
(AP sites), as well as bulky DNA lesions including a cisplatin adduct, propano-2’deoxyguanosine (PdG), benzo(a)pyrene expoxide (BaP), DNA adduct, BaP-dG adduct,
pyrimidine(6-4)pyrimidone photoproduct (6,4-PP) and cyclobutane pyrimidine dimer
(CPD) (Bassett et al., 2002a; Batra et al., 2006; Beard et al., 2009; Chary et al., 2012a;
Efrati et al., 1997; Hashim et al., 1997b; Hoffmann et al., 1996b; Maga et al., 2009b;
Servant et al., 2002b; Vaisman and Chaney, 2000b; Villani et al., 2011b). Because pol β
lacks 3’-5’ exonuclease activity for proofreading, it can insert an incorrect nucleotide to
bypass a DNA base lesion, leading to a high frequency of mutation (Bassett et al., 2002a;
Batra et al., 2006; Beard et al., 2009; Beard and Wilson, 2014; Chary et al., 2012a; Efrati
et al., 1997; Hashim et al., 1997b; Hoffmann et al., 1996b; Servant et al., 2002b; Vaisman
and Chaney, 2000b). For example, during its bypass of an AP site, pol β can insert an
adenosine opposite to the lesion that may ultimately result in C to T transition if the abasic
site is originally derived from an 8-oxoG (Beard et al., 2009). Pol β bypass of bulky DNA
adducts such as Pt-adducts can also induce mutations in the genome with a high frequency
(Bassett et al., 2002a; Batra et al., 2006; Chary et al., 2012a; Hashim et al., 1997b;
Hoffmann et al., 1996b; Servant et al., 2002b; Vaisman and Chaney, 2000b). Thus, pol β
lesion bypass DNA synthesis can lead to mutations that may further result in the
development of human cancer.
Previous studies have shown that several Y family DNA translesion synthesis
polymerases can bypass a cdPu lesion during DNA replication with moderate efficiency
(You et al., 2013). It remains to be elucidated whether other DNA repair polymerases that
can bypass DNA base lesions, such as pol β, may also bypass a cdPu during DNA
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replication and repair and whether the lesion bypass of a cdPu by these DNA polymerases

Figure 1.1 The structures of 5’,8-cyclo-2’-deoxyadenosines.	
  

	
  
may affect genome integrity and stability. We hypothesized that pol β can bypass a 5’RcdA and a 5’S-cdA during DNA replication and BER, and this may subsequently cause
genome instability. Our hypothesis is supported by our recent study showing that pol β can
bypass both a 5’R-cdA and 5’S-cdA located in a CAG repeat tract by skipping over the
lesions, thereby resulting in CTG repeat deletion (Xu et al., 2014). To test this hypothesis,
we initially examined DNA synthesis for bypassing a cdA with pol β deficient and
proficient cell extracts. We then characterized pol β DNA synthesis in bypassing a cdA
during DNA replication and BER and determined nucleotide insertions during pol β lesion
bypass of a template cdA. For the first time, we found that pol β efficiently bypassed a 5’RcdA during DNA replication and BER. However, the enzyme bypassed a 5’S-cdA with a
low efficiency. Moreover, we further demonstrated that pol β bypass of a cdA also led to
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nucleotide misinsertions and single-strand DNA breaks, indicating that pol β lesion bypass
of a cdA lesion during DNA replication and repair can induce mutations and strand breaks
in the genome that ultimately results in genome instability.
2. MATERIALS AND METHODS
2.1 Materials
The DNA oligonucleotides containing a 5’R-cdA or 5’S-cdA were synthesized and
purified by HPLC as described previously (Chatgilialoglu et al., 2014). The structures of
5’R-cdA and 5’S-cdA were illustrated in Figure 1.1. All other oligonucleotides were
synthesized

by

Integrated

DNA

Technologies

(IDT,

Coralville,

IA,

USA).

Deoxynucleoside 5’-triphosphates (dNTPs) were purchased from Fermentas (Glen Burnie,
MD, USA). Radionucleotides, [γ-32P] ATP (6000 mCi/mmol) and cordycepin 5’triphosphate 3’-[α-32P] (5000 mCi/mmol) were purchased from Perkin Elmer Inc. (Boston,
MA, USA). Micro Bio-Spin 6 chromatography columns were from Bio-Rad (Hercules,
CA, USA). All other standard chemical reagents were from Sigma-Aldrich (St. Louis, MO,
USA) and Thermo Fisher Scientific (Pittsburgh, PA, USA). Purified pol β, flap
endonuclease 1 (FEN1) and DNA ligase I (LIG I) were generous gifts from Dr. Samuel H.
Wilson at the National Institute of Environmental Health Sciences (NIEHS)/National
Institutes of Health, Research Triangle Park, North Carolina.
2.2 Oligonucleotide substrates
Substrates containing a 31-nt template strand with a 5’R-cdA or 5’S-cdA located at
the 19th nucleotide counted from the 3’-end were designed to mimic DNA replication or
BER intermediates with a cdA lesion on the template strand. The upstream primer of the
substrates is an 18-nt strand without or with a 3’-terminus dT that base paired with the
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template cdA. The downstream primer of the substrates is a 13-nt strand with a 5’phosphate or 5’-phosphorylated tetrahydrofuran (THF) residue, an abasic site analog.
Substrates that mimic the lesion bypass intermediates formed during DNA leading
strand synthesis were constructed by annealing an18-nt upstream primer containing a 3’terminus dT with the cdA-containing template strand at a molar ratio of 1:2. Substrates
representing the intermediates with a 1-nt gap opposite a template cdA formed during DNA
lagging strand synthesis and BER were constructed by annealing the 18-nt upstream primer
and a 13-nt downstream primer with a 5’-phosphate or 5’-THF residue with the template
strand containing a 5’R-cdA or 5’S-cdA at a molar ratio of 1:1:2. Substrates were
radiolabeled at the 5’-end of the upstream primers or the 3’-end of downstream primers for
measuring the activities of different enzymes. The sequences of the oligonucleotide
substrates are listed in Table 1.1.

	
  

32	
  

2.3 Translesion DNA synthesis in bypassing a cdA in mouse embryonic fibroblast
(MEF) cell extracts
The MEF cell extracts were prepared according to the procedure described
previously (Biade et al., 1998a). Briefly, pol β null (pol β−/−) and wild-type pol β (pol β+/+)
MEF cells were grown to near confluence. Cells were then harvested and lysed with
rotation at 4 °C in lysis buffer. Cell lysates were then subject to centrifugation at 12,000
rpm for 30 min to obtain whole-cell extracts. The whole-cell extracts were subsequently
dialyzed into BER reaction buffer containing 50 mM Tris-HCl, pH 7.5, 50 mM KCl, 0.1
mM EDTA, 0.1 mg/ml bovine serum albumin and 0.01% Nonidet P-40. Levels of pol β
protein in different cell extracts were determined by immunoblotting using rabbit antimouse pol β antibody (a generous gift from Dr. Samuel H. Wilson at National Institute of
Environmental Health Sciences/National Institutes of Health) (Data not shown). The DNA
synthesis activity was measured by incubating 60 µg of cell extracts with open template
substrates with an upstream primer, that contained a 5’R-cdA or 5’S-cdA on the template
strand, or with gapped substrates with a 1-nt gap opposite a template 5’R-cdA or 5’S-cdA
with a 5'-phosphate or 5'-phosphorylated THF residue. Reaction mixtures were assembled
on ice and incubated at 37 °C for 30 min. Reactions were terminated by addition of 15 µl
of stopping buffer containing 95% formamide and 10 mM EDTA and subsequent
incubation at 95 °C for 5 min. Substrates and DNA synthesis products were separated by
15% or 18% urea-denaturing PAGE and detected by Pharos FX Plus PhosphorImager from
Bio-Rad (Hercules, CA, USA).
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2.4 In vitro BER reconstituted with purified enzymes
In vitro BER of an abasic lesion that is opposite acdA was performed by incubating
purified pol β, FEN1, LIG I with the substrates containing a 1-nt gap opposite a 5’R-cdA
or a 5’S-cdA on the template with a downstream 5’-THF residue. The 10-µl reactions were
reconstituted with the indicated concentrations of BER enzymes and substrates in BER
reaction buffer with 50 µM dNTPs, 5 mM MgCl2 and 2 mM ATP. Reaction mixtures were
assembled on ice and incubated at 37°C for 30 min. Reactions were terminated by addition
of stopping buffer containing 95% formamide and 10 mM EDTA and incubation at 95 °C
for 5 min. Substrates and products were separated by 15% or 18% urea-denaturing PAGE
and detected by Pharos FX Plus PhosphorImager. All substrates were 32P-labeled at the 5’end of the upstream primer.
2.5 Enzymatic activity assays
Lesion bypass synthesis activity of pol β was determined with the open template
and gapped substrates with a 5’R-cdA or 5’S-cdA in the template. Pol β lesion bypass DNA
synthesis activity on the open template was determined with the substrates without or witha
3'-terminus dT that is opposite a template 5’R-cdA or 5’S-cdA. The lesion bypass DNA
synthesis activity was determined at 37 °C for 30 min in a 10-µl reaction mixture in BER
reaction buffer with 50 µM dNTPs and 5 mM MgCl2. Reaction mixtures containing various
concentrations of pol β and 25 nM substrates and BER buffer with 5 mM MgCl2 and 50
µM dNTPs, were assembled on ice and incubated at 37 °C for 30 min. FEN1 cleavage
activity was measured by incubating the substrates containing a 1-nt gap without or with a
downstream 5’-phosphorylated THF with the enzyme in the absence or presence of pol β
in BER buffer with 5 mM MgCl2 and 50 µM dNTP at 37 °C for 30 min. Reactions were
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terminated by addition of stopping buffer containing 95% formamide and 10 mM EDTA
and incubation at 95°C for 5 min. Substrates and products were separated by 15% or 18%
urea-denaturing PAGE and detected by a Pharos FX Plus PhosphorImager.

3. RESULTS
3.1 Pol β plays an important role in bypassing a cdA lesion
Pol β is a key enzyme that plays an essential role in mediating efficient BER in
mammalian cells by removing a 5’-dRP group as well as filling in a single- or multinucleotide gap (Liu and Wilson, 2012). It also plays a critical role in lesion bypass synthesis
during DNA leading and lagging strand synthesis (Maga et al., 2009b; Villani et al., 2011b)
to facilitate Okazaki fragment maturation (Maga et al., 2009b). Therefore, pol β may also
play an important role in bypassing a cdA lesion during DNA replication and BER. To
determine whether pol β can play a role in bypassing a cdA, we initially determined DNA
synthesis in bypassing a 5’R-cdA and 5’S-cdA in cell extracts with pol β deficiency (pol β/-

) and pol β proficiency (pol β+/+) with the open template substrates containing a 5’R-cdA

or 5’S-cdA on the template strand (Figure 1.2A) as well as the 1 nt-gapped substrates
containing a template 5’R- or 5’S-cdA with a 5'-phosphate (Figure 1.2B) and 5’phosphorylated THF residue (Figure 1.2C). The results showed that a significant amount
of lesion bypass products were generated with the substrates containing a template 5’RcdA in pol β+/+ cell extracts (lane 3 of Figure 1.2A, 2B and 2C). However, pol β-/- cell
extracts exhibited very weak lesion bypass synthesis with the substrates (lane 2 of Figure
1.2A, 2B, and 2C). On the other hand, pol β+/+ cell extracts performed weak DNA synthesis
on the substrates containing a template 5’S-cdA (lane 6 of Figure 1.2A, 2B and 2C).
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However, little lesion bypass synthesis products was generated by pol β-/- cell extract with

	
  
the substrates (lane 5 of Figure 1.2A, 2B and 2C). The results showed that in the presence
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of pol β, the amount of lesion bypass products was increased by about 2 to 5-fold (the
bottom panel of Figure 1.2A, 2B and 2C) which indicated that pol β played an important
role in bypassing a cdA lesion during DNA replication and BER.

3.2 Pol β bypasses a 5’R-cdA efficiently and stalls at a 5’S-cdA
Previous studies have shown that some Y family translesion synthesis polymerases
such as pol η can bypass a 5’R-cdA and 5’S-cdA with different efficiency (Kuraoka et al.,
2000; Kuraoka et al., 2001). To further determine if pol β can bypass a 5’R-cdA and 5’ScdA during DNA replication and BER, we examined pol β DNA synthesis in bypassing
cdA lesions by incubating increasing concentrations of purified pol β with open template
substrates, as well as 1 nt-gapped substrates containing a template cdA. The results showed
that with the open template substrates, 10 nM of pol β efficiently bypassed a 5’R-cdA and
performed its multi-nucleotide DNA synthesis (Figure 1.3A, lane 2). With increasing
concentrations of pol β (25 nM and 50 nM), the amount of pol β DNA synthesis products
from bypass of a 5’R-cdA was significantly increased (Figure 1.3A, lanes 3-4). However,
pol β exhibited weak DNA synthesis activity during its bypass of a 5’S-cdA (Figure 1.3A,
lane 6). With increasing concentrations of pol β, the amount of its 1-nt insertion product
was increased along with a slight increase in its multi-nucleotide DNA synthesis (Figure
1.3A, lanes 7-8). The results indicated that pol β efficiently bypassed a 5’R-cdA, but stalled
after it inserted a dT for bypassing a 5’S-cdA. The stalled pol b DNA synthesis suggests
that the base lesion conferred a strong inhibitory effect on polymerase lesion bypass
synthesis during DNA leading strand synthesis. To further determine whether pol β can
continue to perform its lesion bypass synthesis after it inserts one nucleotide that base pairs
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with a template cdA, we examined pol β synthesis activity with the open template
substrates containing a 3’-terminus dT that base paired with a template 5’R-cdA or 5’ScdA (Figure 1.3B). These substrates mimic the intermediates resulting from pol β 1-nt
insertion that are generated during leading strand synthesis. We found that pol β at 10-50
nM performed efficient DNA synthesis to extend a dT, which base paired with a 5’R-cdA
(Figure 1.3B, lanes 2-4). However, the polymerase failed to extend a dT that base paired
with a 5’S-cdA (Figure 1.3B, lanes 6-8), indicating that the 5’S-cdA lesion completely
inhibited pol β DNA synthesis. Similar to its lesion bypass DNA synthesis with the open
template substrates, pol β exhibited efficient DNA synthesis with the 1-nt gapped
substrates containing a 5’R-cdA without or with a 5’-phosphorylated THF residue that
mimic a lagging strand maturation and BER intermediate, respectively (Figure 1.3C, lanes
2-4 and lanes 10-12). However, with the gapped substrates containing a 5’S-cdA, the
enzyme only inefficiently inserted one nucleotide to base pair with the lesion (Figure 1.3C,
lanes 6-8 and lanes 14-16). For the nicked substrates containing a 3’-terminus T that base
paired with a 5’R-cdA without or with a 5’-THF residue, pol b efficiently extended the dT
(Figure 1.3D, lanes 2-4 and lanes 10-12), but failed to extend a 3’-terminus dT that paired
with a 5’S-cdA (Figure 1.3D, lanes 6-8 and lanes 14-16). The results indicated that pol β
effectively bypassed a 5’R-cdA, but stalled at a 5’S-cdA after it inserted a dT that base
paired with the lesion which further suggests that a 5’S-cdA on the template distorted the
DNA double-helix structure. This subsequently disrupted pol β binding to the substrates
and its nucleotide insertion and further inhibited pol β multi-nucleotide DNA synthesis
during its lesion bypass.
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Figure 1.3 Pol β DNA synthesis with a template cdA lesion during DNA replication and BER.
(A) Pol β bypass of a cdA at an open template during DNA replication was examined with the
substrates containing a 5’R-cdA or 5’S-cdA with an upstream primer alone annealed with the
template strand. (B) Pol β DNA synthesis in extending a 3’-terminus dT that base paired with the
template cdA lesion during DNA replication was measured with the open template substrates under
the experimental conditions. For panels (A) and (B), lanes 1 and 5 represent substrates only. Lanes
2–4 and lanes 6–8 correspond to reaction mixtures with 10 nM, 25nM and 50 nM pol β, respectively.
(C) Pol β bypass of a cdA during Okazaki fragment maturation and BER was examined with the
substrates containing a 1-nt gap opposite a template 5’R-cdA or 5’S-cdA and the downstream primer
with a 5’-phosphate or a 5’-phosphorylated THF residue. (D) Pol β DNA synthesis after a template
cdA was bypassed during Okazaki fragment maturation and BER was examined with nick substrates
in which the cdA was base paired with a dT. Pol β DNA synthesis to extend a dT that was base
paired with a template cdA during BER was measured by using nick substrates that contained a
downstream primer with a 5’-phosphorylated THF residue. For both panels (C) and (D), lanes 1, 5,
9 and 13 correspond to substrates only. Lanes 2–4, 6–8, 10–12 and 14–16 correspond to reaction
mixtures with 5, 10 and 25nM pol β, respectively. Substrates were 32P-labeled at the 5’-end of the
upstream primer as indicated. Substrates are illustrated schematically above the gel.	
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3.3 FEN1 cleavage activity during pol β lesion bypass of a 5’R-cdA and 5’S-cdA
FEN1 plays an essential role in both Okazaki fragment maturation and long-patch
BER by removing a 5’-flap created by strand displacement synthesis of replicative DNA
polymerases, pol δ/ε, or repair polymerases such as pol β (Balakrishnan and Bambara, 2013;
Liu et al., 2004). Removal of an oxidized or reduced deoxyribose phosphate during longpatch BER is dependent on FEN1 flap cleavage activity (Liu and Wilson, 2012; Wilson et
al., 2010). Because pol β DNA synthesis can result in the formation of a flap, it may affect
FEN1 cleavage. To further determine if FEN1 cleavage during Okazaki fragment
maturation and BER can be affected by pol b lesion bypass of a cdA, we examined FEN1
cleavage activity on the 1 nt-gapped substrates containing a template cdA without or with
a 5’-THF residue in the absence and presence of pol b (Figure 1.4). The results showed
that for the substrates with a template 5’R-cdA, in the absence of pol β, FEN1 mainly
removed 1 or 2 nucleotides from the downstream strand (Figure 1.4, lanes 2 and 8). In the
presence of pol β, FEN1 cleavage was significantly stimulated, and it predominantly
removed a flap containing 5 or 6 nucleotides (Figure 1.4, lanes 3 and 9). This indicated that
after pol b efficiently bypassed a 5’R-cdA, it kept inserting nucleotides to perform strand
displacement synthesis, creating a 5-nt or 6-nt downstream flap for FEN1 cleavage. In
contrast, for the 5’S-cdA containing substrates, in the absence of pol β, FEN1 removed 2
to 4 nucleotides (Figure 1.4, lanes 5 and 11). The presence of pol β did not significantly
alter FEN1 cleavage activity (Figure 1.4, lanes 6 and 12), indicating that pol β failed to
efficiently bypass a 5’S-cdA. This allowed FEN1 to remove more nucleotides than were
inserted by pol β, leaving a gapped intermediate that failed to be sealed by LIG I. This
subsequently led to accumulation of a single-strand break intermediate.
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3.4 A 5’S-cdA lesion disrupts the completion of Okazaki fragment maturation and
BER by inhibiting pol β lesion bypass synthesis
When genomic DNA is under the challenge of oxidative stress, oxidative DNA
damage including 8-oxoGs and cdPus can be generated simultaneously in DNA in vitro
and in vivo at a significant percentage (Belmadoui et al., 2010; Kirkali et al., 2008).
Because cdPus including cdA lesions can only be repaired by nucleotide excision repair
with low efficiency, this allows the accumulation of the lesions in the genome readily. Thus,
8-oxoGs and cdA lesions may occur simultaneously in the complementary strands of DNA
with high frequency, and it is likely that BER of an 8-oxoG and an abasic lesion in one
strand of the genome may encounter a cdA base lesion accumulated in the template strand.
This could allow pol β to perform DNA synthesis to bypass a cdPu lesion, thereby
subsequently altering the efficiency of lagging strand maturation and BER. It has also been
suggested that BER of a uracil opposite a 5’S-cdA is compromised because the lesion can
alter the geometry of duplex DNA (Karwowski et al., 2014). To test this possibility, we
reconstituted DNA lagging strand maturation and BER with the substrates containing a 1nt gap opposite a 5’R-cdA or 5’S-cdA without or witha 5’-THF residue (Figure 1.5). With
the substrates containing a 5’R-cdA, pol β exhibited efficient lesion bypass synthesis
leading to the production of a significant amount of replication and repair products (Figure
1.5, lanes 2-4 and 10-12), indicating that pol β bypass of a 5’R-cdA led to the completion
of lagging strand maturation and BER. However, with the substrates containing a 5’S-cdA,
pol β only inserted a dT to bypass a template 5’S-cdA and failed to further extend the
nucleotide by inserting additional nucleotides (Figure 1.5, lanes 6-8 and 14-16), resulting
in the accumulation of a single-strand DNA break intermediate with a template 5’S-cdA.
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These results demonstrated that inefficient bypass of a 5’S-cdA by pol β prevented the
completion of lagging strand maturation and BER. This further suggests that a 5’S-cdA
induced DNA strand distortion more severely than a 5’R-cdA, thereby inhibiting pol β
lesion bypass and preventing the completion of Okazaki fragment maturation and BER.

	
  
	
  
Figure 1.4 FEN1 flap cleavage during pol β bypass of a cdA. FEN1 flap cleavage on the
substrates containing a 5’-phosphate or 5’-THF residue with a 1-nt gap opposite a template
5’R-cdA or 5’S-cdA was examined as described in Section 2. Lanes 1, 4, 7 and 10 represent
substrates only. Lanes 2, 5, 8 and 11 correspond to reaction mixtures with 10nM FEN1. Lanes
3, 6, 9 and 12 correspond to reaction mixtures with 10nM FEN1 in the presence of 5 nM pol
β. Substrates were 32P-labeled at the 3’-end of the downstream primer as indicated. Substrates
are illustrated schematically above the gel.
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Figure 1.5 Completion of DNA lagging strand maturation and BER through pol β bypass of a
cdA lesion. Reconstituted DNA lagging strand maturation and BER were performed to determine
the effects of pol β bypass of a cdA on completion of DNA lagging strand maturation and BER.
Substrates containing a 5’-phosphate or 5-THF residue with a 1-nt gap opposite a template 5’R-cdA
or 5’S-cdA were incubated with indicated BER enzymes at the experimental conditions described
in Section 2. Lanes 1, 5, 9 and 13 represent substrates only. Lanes 2–4, 6–8, 10–12 and 14–16
correspond to reconstitution reaction mixtures with 10nM FEN1 and 5 nM LIG I in the presence of
5, 10 and 25nM pol β, respectively. Substrates were 32P-labeled at the 5’-end of the upstream primer
as indicated. Substrates are illustrated schematically above the gel.

	
  

3.5 Pol β can bypass a 5’,8-cdA through nucleotide misinsertion during DNA
replication and BER
Previous studies have shown that cdA lesions can completely block DNA synthesis
of human replication polymerases such as pol δ, causing replication fork stalling through
inducing the distortion of DNA backbone (Kuraoka et al., 2000). To resolve the stalled

43	
  

replication fork and restart DNA replication, Y family DNA translesion polymerases are
recruited to perform translesion synthesis for bypassing the base lesions (Friedberg et al.,
2005). However, a template 5’S-cdA can also block the lesion bypass synthesis by Y family
polymerases such as pol η and pol ι, resulting in the accumulation of DNA strand breaks
leading to apoptosis (Kuraoka et al., 2001; Pednekar et al., 2014; You et al., 2013). Because
pol β has also been shown to exhibit translesion synthesis to bypass a DNA base lesion
during DNA replication and BER (Bassett et al., 2002a; Chary et al., 2012a; Hashim et al.,
1997b; Hoffmann et al., 1996b; Maga et al., 2009b; Servant et al., 2002b; Vaisman and
Chaney, 2000b; Villani et al., 2011b) Thus, it is possible that pol β can be recruited to
perform translesion synthesis to bypass a cdA lesion. However, several studies have shown
that pol β lesion bypass synthesis can induce a high frequency of mutations in the genome
(Bassett et al., 2002a; Batra et al., 2006; Beard et al., 2009; Beard and Wilson, 2014; Chary
et al., 2012a; Efrati et al., 1997; Hashim et al., 1997b; Hoffmann et al., 1996b; Servant et
al., 2002b; Vaisman and Chaney, 2000b). Furthermore, because of lacking a proofreading
3’-5’ exonuclease activity, high levels of pol β are associated with high mutation rates in a
variety of cancer cells (Canitrot et al., 2000; Scanlon et al., 1989; Srivastava et al., 1999).
To investigate whether pol β bypass of a cdA can induce mutations in the genome, pol β
nucleotide insertion during its bypass of a cdA was determined by incubating the open
template and gapped substrates that contained a template 5’R-cdA or 5’S-cdA with 5 nM
and 50 nM pol β. The results showed that at a low concentration (5 nM), pol β mainly
inserted a dT to base pair with a 5’R-cdA with the open template substrates (Figure 1.6A,
lane 3). However, the enzyme also inefficiently inserted a dA, dC or dG to base pair with
the 5’R-cdA (Figure 1.6A, lanes 2, 4 and 5). On the other hand, the same concentration of
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pol β only inserted dT to base pair with a template 5’S-cdA (Figure 1.6A, lane 8) and failed
to insert a dA, dC or dG to bypass the lesion (Figure 1.6A, lane 7 and lanes 9-10).
Surprisingly, we found that with the 1-nt gapped substrates without a 5’-THF residue, 5
nM pol β efficiently inserted both dT and dC to bypass a template 5’R-cdA (Figure 1.6A,
lanes 13-14) and inefficiently inserted a dA and dG to bypass the lesion (Figure 1.6A, lanes
12 and 15). For the 1-nt gap substrate containing a 5’S-cdA, 5 nM pol β mainly inserted a
dT to bypass the lesion (Figure 1.6A, lane 18). It also inserted a dA with a very low
efficiency (Figure 1.6A, lane 17), but it failed to insert dC and dG (Figure 1.6A, lanes 1920). For the 1-nt gap substrates with a 5’-THF residue, 5 nM pol β predominantly inserted
a dT and dC to bypass a 5’R-cdA (Figure 1.6A, lanes 23-24), although the enzyme also
managed to insert a dA and dG inefficiently to bypass the lesion (Figure 1.6A, lanes 22
and 25). The same concentration of pol β inefficiently inserted a dT to bypass a 5’S-cdA
(Figure 1.6A, lane 28) and failed to insert other types of nucleotides to bypass the lesion
(Figure 1.6A, lanes 27, 29 and 30). At a high concentration of 50 nM, pol β misinsertion
in bypassing a cdA lesion with all the substrates was significantly increased (Figure 1.6B,
lanes 2, 4-5, lanes 12, 14-15, lanes 17, 19-20, and lanes 22, 24-25, 27). The high
concentrations also significantly increased pol β correct nucleotide insertion in bypassing
a 5’S-cdA (Figure 1.6B, lanes 8, 18 and 28). However, the high concentrations of pol β
failed to increase the pol β misinsertion of a dA to pair with a 5’S-cdA with the open
template substrate (Figure 1.6B, lane 7). The results indicated that at both a low and high
concentration, pol β efficiently misinserted dC to bypass a 5’R-cdA during DNA lagging
strand maturation and BER. However, a high concentration of pol b also significantly
promoted its misinsertation of dA and dG during its lesion bypass. The results further
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suggest that pol β bypass of a 5’R-cdA or 5’S-cdA lesion during replication and BER may
be mutagenic, especially in the presence of a high level of pol β.

	
  

	
  

Figure 1.6 Pol β nucleotide insertions in bypassing a cdA lesion during DNA replication and
BER. Pol β nucleotide insertion in bypassing a cdA during DNA lagging strand maturation and
BER was examined by incubating the open-template substrates and 1-nt gap substrates that
contained a downstream 5’-phosphate or 5’-THF residue and a template 5’R-cdA or 5’S-cdA with
5 nM (A) or 50nM (B) pol β in the presence of 50 nM dATP or dTTP or dCTP or dGTP,
respectively, under the experimental conditions described in Section 2. In both panels, lanes 1, 6,
11, 16, 21 and 26 represent substrates only. Lanes 2–5, 7–10, 12–15, 17–20, 22–25 and 27–30
correspond to reaction mixtures with 5 nM or 50 nM pol β in the presence of 50 nM dATP, dTTP,
dCTP or dGTP. Substrates were 32P-labeled at the 5’-end of the upstream primer as indicated.
Substrates are illustrated schematically above the gel. 	
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4. DISCUSSION
In this study, for the first time we discovered that pol β played an important role in
bypassing a cdA lesion during DNA replication and BER (Figure 2). We provided the first
evidence that pol β efficiently bypassed a 5’R-cdA via multi-nucleotide insertions, whereas
the enzyme mainly inserted 1 nt to bypass a 5’S-cdA lesion and failed to further perform
its multi-nucleotide lesion bypass DNA synthesis (Figures 2-3). This resulted in disruption
of its DNA synthesis in bypassing a 5’S-cdA during DNA replication and BER.
Furthermore, we discovered that a 5’S-cdA on the template strand also slightly facilitated
FEN1 removal of a long flap (Figure 1.4), suggesting that the lesion induced a distortion
on the DNA structure, thereby promoting dissociation of the downstream DNA strand from
its template. This further resulted in the formation of a flap that can be efficiently cleaved
by FEN1 leaving gapped DNA thereby inhibiting the completion of DNA replication and
repair and leading to accumulation of single-strand intermediates (Figure 1.5). Moreover,
we found that during DNA replication and BER, a low concentration of pol β inserted both
a correct and incorrect nucleotide to bypass a cdA, whereas a high concentration of pol β
stimulated its nucleotide misincorporation in bypassing a cdA (Figure 1.6). Our results
support a model in which a 5’R-cdA induced by ROS during DNA replication or BER can
be efficiently bypassed by pol β. In the presence of a low concentration of pol β, a correct
nucleotide is inserted to base pair with the lesion. Pol β continues to perform strand
displacement synthesis, creating a long flap which is subsequently cleaved by FEN1. This
leads to the production of a nicked DNA that is sealed by LIG I, resulting in no mutation
in the replication and repair products (Figure 1.7, sub-pathway 1, left). However, both a
low and high concentration of pol β can also insert a dC or dG or dA to bypass a 5’R-cdA,
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resulting in mutations (Figure 1.7, sub-pathway 1, right). On the other hand, a template
5’S-cdA induces the DNA distortion promoting dissociation of the downstream strand from
its template strand resulting in the formation of a small flap. Pol β inefficiently inserts a dT
to base pair with a template 5’S-cdA and stalls (Figure 1.7, subpathway 2). Subsequently,
this allows FEN1 to remove more nucleotides than pol β synthesizes, resulting in
accumulation of single-strand DNA break intermediates (Figure 1.7, subpathway 2).
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Figure 1.7 Pol β bypass of a cdA lesion leads to nucleotide misinsertion and DNA strand
breaks during DNA replication and BER. Reactive oxygen species (ROS) can result in
oxidized DNA lesion, including cdAs with two different configurations, 5’R-cdA or 5’S-cdA.,
during DNA replication and BER. A 5’R-cdA can be efficiently bypassed by pol β. In the
presence of low concentration of pol β, a correct nucleotide can be inserted to base pair with a
template cdA lesion. Polβ can continue to perform strand displacement synthesis, resulting in
the formation of a long flap which is subsequently cleaved by FEN1. This leads to a nicked
DNA for LIG I to seal, resulting in no mutation in the replication and repaired product (Subpathway 1, left). However, a low level of pol β can also insert a dC to base pair a cdA, and the
nucleotide misinsertion is promoted at a high level of pol β (Sub-pathway 1, right). This
subsequently results in mutation during DNA replication and BER. On the other hand, a
template 5’S-cdA can induce DNA distortion that promotes dissociation of the downstream
strand from its template strand, thereby leading to the formation of an intermediate with a gap
and short flap (Sub-pathway 2). The lesion also strongly inhibits pol β lesion bypass synthesis
as well as extension of the lesion bypass intermediate (Sub-pathway 2). Subsequently, FEN1
cleaves the flap removing more nucleotides than pol β synthesizes, causing accumulation of
gapped intermediates that can further lead to DNA strand break intermediates (Sub-pathway
2).

	
  
Employing the cell extract-based in vitro approach, we have demonstrated the
involvement of pol β in cdA lesion bypass during DNA replication and repair explicitly.
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Our results obtained from pol β+/+ and pol β-/- MEFs indicate that pol β plays an important
role in bypassing cdA lesions (Figure 1.2). This is also supported by a study from the
Wilson group showing that pol β-/- MEFs exhibited hypersensitivity to the oxidative DNA
damaging agent, hydrogen peroxide than pol β+/+ MEFs (Horton et al., 2002). Because
hydrogen peroxide is the precursor for generating hydroxyl radicals that can subsequently
lead to cdA lesions, this further indicates that the hypersensitivity of pol β-/- MEFs to
hydrogen peroxide results from the accumulation of oxidized DNA lesions including cdA
lesions and DNA strand breaks caused by the deficiency of lesion bypass in the absence of
pol β.
Our results indicate that pol β efficiently bypassed a 5’R-cdA (Figure 1-2). However,
it also inserted a significant amount of incorrect nucleotides to bypass the lesion at a low
concentration (5 nM), and this was significantly stimulated at a high concentration (50 nM)
(Figure 6). Given the fact that in mammalian cells, during BER of oxidative DNA damage,
a large number of pol β molecules can be recruited to damaged sites resulting in a high
concentration of the enzyme that is accumulated at oxidized base lesions (Lan et al., 2004),
it is likely that pol β nucleotide misinsertions can frequently occur during its bypass of a
cdA in cells. This can then lead to a high frequency of mutations in genomic DNA. Our
results are also consistent with previous findings showing that in human cancer cells, pol
β protein level has been increased significantly compared with normal cells, thereby
inducing a high frequency of mutations (Canitrot et al., 2000; Scanlon et al., 1989;
Srivastava et al., 1999). Moreover, because of the lack of an intrinsic 3’-5’ exonuclease,
pol β lesion bypass can induce more mutations in the genome than replication polymerases
through its nucleotide misinsertion during its lesion bypass synthesis (Beard et al., 2014).
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It is conceivable that an extrinsic 3’-5’ exonuclease that can remove a mismatched base
may improve pol β fidelity during its bypass of a template cdA. It has been reported that in
addition to its cleavage of an abasic site during BER, APE1 also has 3’-5’ exonuclease
activity that can remove mismatched bases at the 3’-end in nicked or gapped DNA (Chou
and Cheng, 2002; Parsons et al., 2005). Previous studies have also found that p53 can
efficiently remove a misinserted base prior to the extension of the mismatched 3’-terminus
by a DNA polymerase (Bakhanashvili, 2001; Rahav, 2013). Because APE1 can form a
complex with pol β (Liu et al., 2007b), and p53 can interact with pol β (Zhou et al., 2001),
it is possible that these proteins may cooperate with pol β to remove a misinserted
nucleotide incorporated by pol β during its bypass of a cdA lesion. It is of interest to
determine if APE1 and p53 can remove a mismatched base that pairs with a template 5’RcdA, improving pol β fidelity during its lesion bypass synthesis of a 5’,8-cyclopurine-2’deoxynucleoside.
Our results also demonstrated that bypass of a 5’S-cdA is a challenge for pol b
(Figures1.2, 1.3). We found that pol β failed to extend the 3'-terminus after it inserted one
nucleotide to base pair with a 5’S-cdA. This subsequently results in the accumulation of
single-strand break intermediates that may subsequently lead to double-strand breaks and
cell death. Previous studies have shown that pol β DNA synthesis in bypassing an AP site
during Okazaki fragment maturation can be promoted by proliferating cell nuclear antigen
(PCNA) and replication protein A (RPA) (Maga et al., 2009b). It has been also shown that
through coordination with FEN1 and RPA, pol β strand displacement synthesis activity is
also facilitated after it bypasses an abasic site (Maga et al., 2009b). It is conceivable that
the replication and repair cofactors that can facilitate pol β lesion bypass activity and primer
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extension may facilitate pol β bypass of a 5’S-cdA as well as its extension of the lesion
bypass intermediates. Therefore, it is of interest to investigate how BER cofactors, PCNA
and RPA may also facilitate pol β bypass of a 5’S-cdA, preventing the formation of DNA
strand break intermediates and cell death.
In summary, we identified that pol β played an important role in bypassing a
template cdA lesion during DNA replication and BER. We provided the first evidence that
pol β can efficiently bypass a 5’R-cdA, but inefficiently bypass a 5’S-cdA, resulting in the
incompletion of DNA replication and repair and accumulation of strand break
intermediates. Moreover, we found that pol β inserted an incorrect nucleotide to bypass a
cdA, and this was promoted by a high concentration of pol β, indicating that the fidelity of
pol β bypass of a cdA lesion during DNA replication and BER can be modulated by the
concentrations of pol β. This may further result in mutations in the genome. In addition,
we demonstrated that a template 5’S-cdA severely inhibited pol β lesion bypass synthesis
and induced dissociation of the downstream strand from the template strand resulting in
the formation of a short flap (Figure 1.4 and Figure 7 sub-pathway 2). This subsequently
led to poor pol β DNA synthesis along with relatively efficient FEN1 flap cleavage on the
downstream strand, resulting in the accumulation of strand break intermediates (Figure 1.5,
lanes 6-8 and lanes 14-16). Our results reveal that pol β bypass of a cdA can result in
nucleotide misinsertions and DNA strand breaks during DNA replication and BER, thereby
resulting in genome instability.
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CHAPTER 2
AP ENDONUCLEASE 1 COMBATS THE EXTENSION OF A T/G MISMATCH BY
DNA POLYMERASE β TO PREVENT MUTATIONS IN CpGs DURING BASE
EXCISION REPAIR
ABSTRACT
Dynamics of DNA methylation and demethylation at CpG clusters are involved in
gene regulation. CpG clusters have been identified as hot spots of mutagenesis because of
their susceptibility to oxidative DNA damage. Damaged Cs and Gs at CpGs can disrupt a
normal DNA methylation pattern through modulation of DNA methylation and
demethylation, leading to mutations and deregulation of gene expression. DNA base
excision repair (BER) plays a dual role of repairing oxidative DNA damage and mediating
an active DNA demethylation pathway on CpG clusters through removal of a T/G
mismatch resulting from deamination of a 5mC adjacent to a guanine that can be
simultaneously damaged by oxidative stress. However, it remains unknown how BER
processes clustered lesions in CpGs and what are the consequences from the repair of these
lesions. In the present study, we examined BER of an abasic lesion next to a DNA
demethylation intermediate, the T/G mismatch in a CpG dinucleotide, and its effect on the
integrity of CpGs. Surprisingly, we found that the abasic lesion completely abolished the
activity of thymine DNA glycosylase (TDG) for removing the mismatched T. However,
we found that APE1 could still efficiently incise the abasic lesion leaving a 3-terminus
mismatched T, which was subsequently extended by pol β. This in turn resulted in a C to
T transition mutation. Interestingly, we also found that APE1 3’-5’ exonuclease activity
efficiently removed the mismatched T, thereby preventing pol β extension of the
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mismatched nucleotide and the resulting mutation. Our results demonstrate a crucial role
of APE1 3’-5’ exonuclease activity in combating mutations in CpG clusters caused by an
intermediate of DNA demethylation during BER.
1. INTRODUCTION
Dynamics of cytosine methylation, i.e., formation of 5-methyl cytosine (5mC) and
demethylation of 5mC in CpG islands (CGIs), in the mammalian genome are actively
involved in the regulation of gene expression, inactivation of the X chromosome, and gene
imprinting, among others (Bhutani et al., 2011; Chen and Riggs, 2011; Jones, 2012; Jones
and Takai, 2001). It is estimated that only approximately 1-2% of cytosines in the
mammalian genome are unmethylated (Bird et al., 1985; Bird, 1986; Illingworth et al.,
2008; Suzuki and Bird, 2008), whereas 60-90% of CpGs are methylated (Jones and Takai,
2001; Siegfried and Cedar, 1997). The DNA methylation pattern regulates gene
transcription by facilitating or blocking access of transcription factors to gene promoter or
transcribed regions directly (Becker et al., 1987; Tate and Bird, 1993), or by modulating
the recruitment of methyl CpG binding proteins (Lewis et al., 1992; Meehan et al., 1989;
Tate et al., 1996), as well as by altering histone modifications and chromatin structures
(Berger, 2002; Cheung et al., 2000; Clark et al., 1997; Hendrich and Bird, 1998). A normal
DNA methylation pattern is essential for maintaining the homeostasis of gene expression
and cellular function, whereas an aberrant DNA methylation pattern is associated with the
onset and progression of many diseases (Jones and Baylin, 2007; Robertson, 2005;
Valinluck and Sowers, 2007). It has been found that hypermethylation of CpGs on tumor
suppressor genes (TSGs) (Rideout et al., 1990; Stirzaker et al., 1997) and hypomethylation
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of CpGs on oncogenes result in deregulation of expression of the genes leading to the
development of cancer (Jones, 2012).
5-methylcytosine (5mC) can be removed by a process called DNA demethylation,
which can occur either passively or actively. Passive DNA demethylation results from the
failure of DNA methyltransferases to methylate a cytosine during DNA replication and cell
division (Bhutani et al., 2011). Passive DNA demethylation may also result from the loss
or substitution of cytosines by DNA damage and repair in the context of CpGs. Active
DNA demethylation is mediated by sequential enzymatic reactions that can occur
independent of DNA replication and cell division (Bhutani et al., 2011; Chen and Riggs,
2011; Cortellino et al., 2011; Zhu, 2009). Removal of a 5mC by active DNA demethylation
is initiated by modifications of the nucleotide through several types of enzymatic reactions,
including hydroxylation, deamination and oxidation that convert the 5mC into a modified
base or base lesion that is recognized and cleaved by DNA glycosylases (Bhutani et al.,
2011; Chen and Riggs, 2011) which subsequently leads to replacement of the 5mC through
the DNA base excision repair (BER) pathway (Bhutani et al., 2011; Chen and Riggs, 2011;
Cortellino et al., 2011). It has been shown that BER-mediated active DNA demethylation
is accomplished through several pathways depending on the type of modifications of 5mC
that are removed by different types of DNA glycosylases (Bhutani et al., 2011; Chen and
Riggs, 2011; Gehring et al., 2009; Zhu, 2009). One of the pathways is initiated by a direct
deamination of 5mC by activation-induced cytidine deaminase (AID) that converts a 5mC
to a thymine, resulting in a T/G mismatch (Morgan et al., 2004). The mismatched T can be
subsequently excised by thymine DNA glycosylase (TDG) (Cortellino et al., 2011;
Neddermann and Jiricny, 1993, 1994; Zhang et al., 2012), leaving an abasic site that is then
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subjected to BER which ultimately leads to replacement of the 5mC with an unmethylated
C (Bhutani et al., 2011). Another BER-mediated DNA demethylation pathway is initiated
by single-strand-selective monofunctional uracil-DNA glycosylase 1 (SMUG1) that
removes a 5-formyluracil generated from oxidation of a 5mC by a family of enzymes called
Ten Eleven Translocation (TET), a methylcytosine dioxygenase (He et al., 2011; Ito et al.,
2011; Williams et al., 2011), or from oxidative DNA damage induced by hydroxyl radicals
(Bjelland et al., 1995; Masaoka et al., 2003). Thus, in mammalian cells, DNA base damage
and BER are strategically used as a mechanism for both passive and active DNA
demethylation (Gehring et al., 2009).
While the cytosine in a CpG dinucleotide is a substrate for DNA methylation and
demethylation, the neighboring 3’-guanine is a hotspot of oxidative DNA damage. As the
most abundant form of oxidative DNA damage in mammalian cells, 8-oxoguanine (8-oxoG)
readily accumulates in CpGs and may affect the integrity of CpGs by modulating the
production and processing of DNA demethylation intermediates. It has been found that 8oxoG can cause accumulation of T/G mismatched base pairs when it occurs adjacent to
5mC by inhibiting the removal of the mismatched T (Sassa et al., 2014). Moreover, when
BER of 8-oxoG encounters active DNA demethylation, repair of the lesion may be affected
by a DNA demethylation intermediate which has been supported by a recent study from
the Wilson group showing that the efficiency of removal of 8-oxoG by OGG1 was
significantly reduced by an adjacent 5’-T/G mismatch, a DNA demethylation intermediate
generated from deamination of 5mC in CpGs (Sassa et al., 2014). This subsequently
inhibited the completion of BER. This suggests that a base lesion interferes with an
essential step of BER-mediated DNA demethylation, thereby compromising the efficiency

56	
  

and fidelity of DNA demethylation in CpGs. These studies further suggest that BER of
oxidative DNA damage in CpGs and DNA demethylation intermediates has to be properly
coordinated to maintain the integrity and fidelity of CpGs. However, it remains unknown
how the fidelity of CpGs may be maintained by BER in coordinating its dual function in
repairing a base lesion as well as in mediating active DNA demethylation. In the current
study, we explored how an abasic lesion that occurs in a CpG at the 3’-side of a T/G
mismatch could affect the integrity of a CpG dinucleotide by modulating the removal of
the mismatched T during BER, and how BER may coordinate the removal of the base
lesion and maintenance of the fidelity of CpG dinucleotides. For the first time, we show
that the abasic lesion completely inhibited the removal of its adjacent 5’-mismatched T by
TDG leading to accumulation of the mismatched nucleotide. We show that DNA
polymerase β (pol β) readily tolerated the mismatched T and efficiently extended the
mismatched nucleotide, allowing the sustainment of the T/G mismatch and leading to a C
to T transition mutation during BER. Interestingly, we discovered that AP endonuclease 1
(APE1) 3’-5’ exonuclease efficiently removed the mismatched T, thereby preventing the
mutation. Our results indicate that APE1 3’-5’ exonuclease plays a crucial role in
maintaining the integrity of CpGs during BER and DNA demethylation. This demonstrates
that the coordination between BER enzymes effectively removes a 3’-mismatched T, thus
preventing mutations that result from BER and BER-mediated active DNA demethylation.
Our study provides new insights into the molecular mechanisms underlying the roles of
BER in preventing T/G mismatches and sustaining the integrity of CpGs during BER and
active DNA demethylation.
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2. MATERIALS AND METHODS
2.1 Materials
Oligonucleotides were synthesized by Integrated DNA Technologies Inc.
(Coralville, IA). The radionucleotides [γ-32P] ATP (6000 Ci/mmol) and cordycepin 5'triphosphate 3'- [α-32P] (5000 Ci/mmol) were purchased from PerkinElmer Inc. (Boston,
MA).Micro Bio-Spin 6 chromatography columns were from Bio-Rad (Hercules, CA). T4
polynucleotide kinase (PNK) and terminal deoxynucleotidyl transferase (TdT) were from
Fermentas (Glen Burnie, MD). Adenosine 5’-triphosphate (ATP) (100 mM) was from USB
(Cleveland, Ohio). Purified thymine DNA glycosylase (TDG) was from Enzymax, LLC
(Lexington, Kentucky). Purified APE1, pol β, flap endonuclease 1 (FEN1) and DNA ligase
I (LIG I) were generous gifts from Dr. Samuel H. Wilson at the Genome Integrity and
Structural

Biology

Laboratory,

National

Institute

of

Environmental

Health

Science/National Institutes of Health (NIEHS), Research Triangle Park, NC. All other
reagents were from Thermo Fisher Scientific (Pittsburgh, PA) and Sigma-Aldrich (St.
Louis, MO).
2.2 Oligonucleotide substrates
An oligonucleotide substrate containing a T/G mismatched base pair adjacent to a
G/C matched base pair or a tetrahydrofuran (THF), an abasic site analog, was designed to
mimic the intermediates resulting from deamination of a 5-methylcytosine by AID in a
CpG dinucleotide with an undamaged G or an abasic lesion (AP site) that substituted G.
Substrates containing a T/G mismatch at the upstream primer and a 5’-THF residue at the
downstream primer were designed to mimic the BER intermediates containing an oxidized
AP site adjacent to a T/G mismatch that is 5’-incised by APE1 opposite to a template C or
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T. The substrate containing an intact or preincised AP site opposite to a template C and
adjacent to a C/G matched base pair was used as the control. Substrates for measuring TDG
activity were constructed by annealing the strand containing a T with the template strand
containing a G that was base paired with the T at a molar ratio of 1:1.5. Substrates for
measuring BER enzymatic activity were constructed by annealing the upstream primer
with a 3’-T that mispaired with a template G and the downstream primer with a 5’-THF
residue to the template strand at a molar ratio of 1:1:2. The sequences of the oligonucleotide
substrates are listed in Table 2.1.
Table 2.1 Sequences of the oligonucleotide substrates
nt
Sequence (5’-3’)
Oligonucleotides
Damaged Strands
31
GCA CCG GAT CCG CAC CTG GCA TCA GCT GCA
D1
G
30
GCA CCG GAT CCG CAC CTF GCA TCA GCT GCA
D2
G
Upstream Strands
37
CGA GTC ATC TAG CAT CCG TAG CAC CGG ATC
US1
CGC ACC C
37
CGA GTC ATC TAG CAT CCG TAG CAC CGG ATC
US2
CGC ACC T
Downstream
Strands
33
pF-GCA TCA GCT GCA GTA CGT AGA CTT ACT
DS1
CAT TGC
Template Strands
31
CTG CAG CTG ATG CCG GGT GCG GAT CCG GTG
T1
C
71
GCA ATG AGT AAG TCT ACG TAC TGC AGC TGA
T2
TGC CGG GTG CGG ATC CGG TGC TAC GGA TGC
TAG ATG ACT CG
71
GCA ATG AGT AAG TCT ACG TAC TGC AGC TGA
T3
TGC TGG GTG CGG ATC CGG TGC TAC GGA TGC
TAG ATG ACT CG
a
The damaged base is in boldface. F, tetrahydofuran.
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2.3 Measurement of TDG activity in removing a T/G mismatch adjacent to a THF
residue, an analogue of an AP site
The TDG activity for removing the T from a T/G mismatch adjacent to a THF
residue was measured by incubating increasing concentrations of TDG from 50 nM to 70
nM with 25 nM substrate containing a T/G mismatch with or without the THF residue. The
activity was examined at 37 oC for 30 min in 10 µl reaction buffer with 50 mM Tris-HCl,
pH 7.5, 1 mM EDTA, 1 mM DTT, 0.1 mg/ml BSA, and 0.01% Nonidet P-40. Reactions
were terminated by transferring to 95 oC for 5 min. The reaction mixture was then treated
with 0.1 M NaOH and denatured at 95oC for 10 min in buffer containing 95% formamide
and 10 mM EDTA. Substrates and products were separated by 15% urea-denaturing
polyacrylamide gel electrophoresis (PAGE) and detected by a Pharos FX Plus Imager (Biorad Laboratories, Hercules, CA).
2.4 Measurement of APE1 activity in removing an abasic site adjacent to a T/G
mismatch
The APE1 incision of the THF residue, an abasic site analog, that is adjacent to
5mC or a T/G mismatch, was measured at 37 oC in a 20 µl reaction mixture containing 50
mM Tris-HCl, pH 7.5, 50 mM KCl, 0.1 mM EDTA, 0.1 mg/ml BSA, 5 mM MgCl2, and
0.01% Nonidet P-40. APE1 activity was examined by incubating 5 nM APE1 with 25 nM
substrate containing the THF residue adjacent to a mismatched T or matched C/G in the
absence and presence of increasing concentrations of TDG (10, 25, 50 and 70 nM).
Reactions were terminated by transferring to 95 oC for 5 min in stopping buffer containing
95% formamide and 10 mM EDTA. Substrates and products were separated by 15% ureadenaturing PAGE and detected by a Pharos FX Plus Imager.
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2.5 Measurement of pol β DNA synthesis activity in extending the 3’-terminus
mismatched T of a T/G mismatch
The Pol β DNA synthesis on a single-nucleotide gapped substrate to extend a 3’mismatched T or 3’-matched C was measured using a one-nucleotide gapped substrate
containing a T/G mismatch or a C/G match at the 3’-terminus of the upstream primer and
a 5'-THF residue at the downstream primer. Enzymatic reactions were performed by
incubating 25 nM substrate with various concentrations of pol β at 37 oC for 15 min in a
10 µl reaction mixture containing BER buffer (50 mM Tris-HCl, pH 7.5, 50 mM KCl, 0.1
mM EDTA, 0.1 mg/ml BSA, 0.01% Nonidet P-40, 5 mM MgCl2). APE1 3’-5’ exonuclease
activity of removing the T from the 3’-T/G mismatch was measured in BER buffer at 37
o

C for 15 min. FEN1 cleavage activity on the THF residue was examined in BER reaction

buffer with 50 µM dNTPs in the absence or presence of 5 nM pol β at 37 oC for 15 min.
Reactions were terminated by transferring to 95 oC for 5 min in stopping buffer containing
95% formamide and 10 mM EDTA. Substrates and products were separated by 15% ureadenaturing PAGE and detected by a Pharos FX Plus Imager.
2.6 Measurement of the efficiency of pol β and APE1 activities in the context of a 3’T/G mismatch
The efficiency of pol β and APE1 in extending or removing a 3'-terminus
mismatched T was determined by measuring pol β gap-filling synthesis activity and APE1
3’-5’ exonuclease activity at various time intervals. Reactions were conducted by
incubating 25 nM 5’-32P-labeled substrate with 5 nM pol β or increasing concentrations of
APE1 alone at 5 nM, 50 nM, and 100 nM. The reaction mixture was assembled on ice and
incubated at 37 oC for 1, 2, 5, 10, 15, and 30 min intervals. Reactions were subsequently
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terminated by transferring to 95 oC for 5 min in stopping buffer containing 95% formamide
and 10 mM EDTA. Substrates and products were separated by 15% urea-denaturing PAGE
and detected by a Pharos FX Plus Imager.
2.7 In vitro reconstituted BER assay
The BER in the context of a T/G mismatch was reconstituted with purified APE1,
pol β, FEN1, LIG I and the 1 nt-gapped substrate with a 3’-terminus matched C/G or T/G
mismatch on the upstream primer, and a THF residue on the downstream primer opposite
a template C or T. Ten microliter reaction mixture contained BER buffer (50 mM TrisHCl, pH 7.5, 50 mM KCl, 0.1 mM EDTA, 0.1 mg/ml BSA, 0.01% Nonidet P-40, 5 mM
MgCl2), 25 nM substrate, 5 mM Mg2+, 50 µM dNTPs, 2 mM ATP and the indicated
amounts of BER enzymes. The reaction mixture was assembled on ice and incubated at 37
o

C for 15 min. Reactions were terminated by transferring to 95 oC for 5 min in stopping

buffer containing 95% formamide and 10 mM EDTA. Substrates and products were
separated by 15% urea-denaturing PAGE and detected by a Pharos FX Plus Imager.
2.8 Sequencing of repair products resulting from BER of an abasic lesion adjacent to
a T/G mismatch
The BER of an abasic lesion adjacent to a T/G mismatch was performed by
incubating 50 nM purified APE1, 5 nM pol β, 50 nM FEN1, and 5 nM LIG I with 25 nM
1 nt-gapped substrate with a 3’-terminus T/G mismatch on the upstream primer, and a 5’THF residue on the downstream primer. The BER reaction (20 µl) was reconstituted with
the indicated concentrations of BER enzymes and substrates in BER reaction buffer (50
mM Tris-HCl, pH 7.5, 50 mM KCl, 0.1 mM EDTA, 0.1 mg/ml BSA, 0.01% Nonidet P40, 5 mM MgCl2) that contained 50 µM dNTPs, 5 mM Mg2+ and 2 mM ATP. The reaction
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mixtures were assembled on ice, and incubated at 37°C for 15 min. Reactions were then
terminated by transferring to 95°C for 10 min. To isolate the repair products, the template
strand of the substrate was biotinylated at the 5’-end. The repair products were incubated
with avidin agarose beads (Pierce-Thermo Scientific, Rockford, IL) in binding buffer that
contained 0.1 M phosphate, 0.15 M NaCl, pH 7.2 and 1% Nonidet P-40 at 4°C for 2 h with
rotation. The agarose beads were centrifuged at 5000 rpm for 1 min and were washed three
times with binding buffer. The repaired strands were then separated from their template
strands through incubation in 0.15 M NaOH for 15 min with rotation under room
temperature, followed by centrifugation at 5000 rpm for 2 min. The repaired strands were
then precipitated with ethanol and dissolved in TE buffer. The repair products were then
subjected to PCR amplification with a forward primer (5’-GCA GTC CTC TAG TCG TAG
TAG-3’) and a reverse primer (5’-GCA ATG AGT AAG TCT AGC TAC TAC-3’). The
PCR amplification was performed under the following conditions: 95°C for 5 min, 1 cycle;
95°C for 30 s, 55°C for 30 s and 72°C for 1 min, 35 cycles; 72°C for 30 min. The PCR
products were then subjected to TA cloning using a TA cloning kit by following the
manufacturer’s instructions (Thermo Fisher Scientific, Pittsburgh, PA). White colonies
were picked for amplifying plasmids that contained the inserts (repair products). Plasmids
were isolated with a Miniprep plasmid isolation kit (Promega, Madison, WI), dissolved in
TE buffer (10 mM Tris-HCl, pH 7.5, and 1 mM EDTA), and subjected to DNA sequencing.
Sequencing reactions were performed with the BigDye Terminator v3.1 Cycle Sequencing
Kit (Thermo Fisher Scientific, Pittsburgh, PA) and were subjected to capillary
electrophoresis (Florida International University DNA Sequencing Core Facility).
Sequencing results were analyzed by MacVector 12.5.1 (MacVector, Apex, NC).
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3. RESULTS
3.1 TDG is completely inhibited by an abasic lesion
In CpG dinucleotide clusters, a 5mC can be converted to a T during active DNA
demethylation, thereby resulting in a T/G mismatch (Morgan et al., 2004). On the other
hand, guanines serve as hot spots of oxidative DNA damage, and guanines located in CpG
dinucleotide clusters can be damaged leading to the production of a base lesion such as an
abasic site adjacent to the 5mC. However, it remains unknown whether an abasic lesion
can affect TDG removal of a T/G mismatch. To test this possibility, we initially examined
the removal of the mismatched T from a T/G mismatch adjacent to an abasic site by TDG.
A substrate containing a mismatched T/G adjacent to an abasic site analog, a THF residue,
was used to mimic the intermediate with an abasic lesion generated after deamination of
5mC. This would allow TDG to remove the 3’-mismatched T generating a native abasic
site, which was subsequently broken by a high temperature at 95 °C into single-strand break
intermediates as TDG products. The results showed that 50 nM TDG removed the
mismatched T next to a normal G (Figure 2.1, lane 2). Its activity was significantly
increased with increasing concentrations of TDG from 60 nM to 70 nM (Figure 2.1, lanes
3-4). Surprisingly, the same concentrations of TDG (50 to 70 nM) failed to remove a
mismatched T next to an abasic site (Figure 2.1, lanes 6-8). This indicated that TDG activity
was completely inhibited by an abasic lesion adjacent to a T/G mismatch. This further
suggests that the presence of an abasic lesion next to an intermediate of 5mC demethylation
in CpG dinucleotide clusters can lead to accumulation of T/G mismatches.
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Figure 2.1 The activity of TDG in removing a T/G mismatch at a CpG dinucleotide is inhibited
by an adjacent abasic lesion. An oligonucleotide substrate that contained random DNA sequence
with a THF residue next to a 5’-T/G mismatch in a CpG dinucleotide was used to mimic a BER
intermediate generated from removal of 8-oxoGby OGG1 and deamination of 5mC. The substrate
that contained a G with a 5’-T/G mismatch was employed to mimic an intermediate generated by
deamination of 5mC alone. TDG activity in removing a T/G mismatch was measured as described
in “Materials and methods”. Substrates were32P-labeled at the 5’-end of the damaged strand. Lanes
1 and 5 correspond to the substrate only. Lanes 2 and 6 correspond to reaction mixtures with 50 nM
TDG. Lanes 3 and 7 correspond to reaction mixtures with 60 nM TDG. Lanes 4 and 8 correspond
to reaction mixtures with 70 nM TDG.TDG cleavage products are indicated. Substrates are
illustrated schematically above the gel.	
  

3.2 APE1 can efficiently incise an abasic site that is adjacent to a T/G mismatch in the
presence of TDG
To further determine if a 3’-mismatched T affects APE1 activity, APE1 5’-incision
of an abasic site adjacent to a T/G mismatch was examined in the absence and presence of
TDG. Substrates containing a 3’-mismatched T next to a THF residue opposite to a C or a
T were used for measuring APE1 activity. The substrates mimic the intermediates
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generated by deamination of the 5mC on the damaged strand alone or the 5mCs on both
the damaged strand and template strand simultaneously. The results showed that 5 nM
APE1 efficiently carried out 5’-incision of an abasic site in the absence and presence of
TDG (Figure 2.2, lanes 2-6 and lanes 8-12).
3.3 Pol β can efficiently extend the 3’-mismatched T of a T/G mismatched base pair
Since APE1 5’-incision of an abasic site next to a T/G mismatch resulted in the 1nt gap intermediate with a 3’-mismateched T, which would be subsequently passed to pol
β for continuation of repair of the lesion, we then asked if pol β could still perform DNA
synthesis in the presence of a 3’-mismatched T. To test this, we examined pol β gap-filling
synthesis using the substrates with a 3’-matched C or a 3’-mismatched T adjacent to a preincised THF residue or a 3’-T along with a template T opposite a preincised THF residue.
We found that 1 nM, 5 nM and 10 nM pol β efficiently extended the 3’-matched C (Figure
2.3, lanes 2.4). However, surprisingly, pol β also efficiently extended a 3’-mismatched T
(Figure 2-3, lanes 6-8 and lanes 10-12), particularly at the concentrations of 5 nM and 10
nM (Figure 2-3, lanes 7-8 and 11-12). For all substrates, pol β mainly inserted one
nucleotide to extend the 3’-terminus T and fill in the gap. Interestingly, pol β extension of
a 3’-mismatched T with a template T was much weaker than its synthesis with a template
C, indicating that the polymerase had difficulty in extending a 3’-mismatched T when it
incorporated A to base pair with a template T. The results further suggest that pol β can
tolerate a 3’-terminus mismatched nucleotide, similar to DNA translesion synthesis
polymerases such as pol κ and pol µ that exhibit mismatch tolerance (Wolfle et al., 2003;
Zhang et al., 2001). Moreover, pol β extension of a 3’-terminus matched C, but not 3’mismatched T resulted in small amount of products with more than one nucleotide insertion
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(Figure 2-3, lanes 3-5). This indicates that pol β performed strand-displacement synthesis
to extend a 3’-matched C, however it failed to perform this synthesis when it extended a
3’-mismatched T indicating that the mismatched base inhibited further pol β DNA
synthesis. In conclusion, pol β tolerated and efficiently extended a 3’-mismatched T
resulting from deamination of a 5mC in CpG dinucleotides during BER.

	
  

	
  

Figure 2.2 APE1 can efficiently incise an abasic site that is adjacent to a T/G mismatch in
a CpG dinucleotide in the presence of TDG. APE1 5’-incision of an abasic site that is adjacent
to a 5’-T/G mismatch in a CpG dinucleotide was examined under the conditions described in
“Materials and methods”. Substrates were 32P-labeled at the 5’-end of the damaged strand. Lanes
1 and 7 correspond to the substrate only. Lanes 2 and 8 correspond to reaction mixtures with 5
nM APE1 alone. Lanes3 and 9 correspond to reaction mixtures with 5 nM APE1 in the presence
of 10 nM TDG. Lanes 4 and 10 correspond to reaction mixtures with 5 nM APE1 in the presence
of25 nM TDG. Lanes 5 and 11 correspond to reaction mixtures with 5 nM APE1 in the presence
of 50 nM TDG. Lanes 6 and 12 correspond to reaction mixtures with 5 nM APE1in the presence
of 75 nM TDG. Substrates and APE1 cleavage products are indicated. The substrates are
illustrated schematically above the gel.
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Figure 2.3 Pol β extends a 3’-terminus mismatched T at a CpG dinucleotide. Polβ DNA
synthesis in the context of a T/G mismatch was examined as described in “Materials and
methods”. Substrates were designed to mimic a BER intermediate containing a 3’-terminus
matched C, or 3’-terminus mismatched T in a CpG dinucleotide with an abasic site preincised
by APE1 opposite to a C or T on the template strand. Substrates were32P-labeled at the 5’-end
of the damaged strand. Lanes 1, 5, and 9 correspond to the substrate only. Lanes 2, 6, and 10
correspond to reaction mixtures with 1 nM polβ. Lanes 3, 7, and 11 correspond to reaction
mixtures with 5 nM polβ. Lanes 4, 8, and 12 represent reaction mixtures with 10 nM polβ.
Substrates and pol β DNA synthesis products are indicated. Substrates are illustrated
schematically above the gel.

	
  
3.4 APE1 3’-5’ exonulcease activity efficiently removes a 3’-mismatched T
It has been reported that APE1 3’-5’ exonuclease activity can remove mismatched
nucleotides (Chou and Cheng, 2002; Cistulli et al., 2004; Liu et al., 2007b). Thus, we
further hypothesized that APE1 might also remove the 3’-mismatched T from a T/G
mismatch to increase the fidelity of pol β in a CpG dinucleotide. To test the hypothesis, we
examined APE1 3’-5’ exonuclease activity on the substrate (25 nM) with a 3’-matched C
or 3’-mismatched T on the upstream strand and a 5’-THF residue on the downstream strand
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with a template C or T opposite an abasic site. We found that APE1 (5 nM, 10 nM, 25 nM
and 50 nM) exhibited poor cleavage activity to remove the 3’-matched C (Figure 2.4, lanes
2-5), indicating inefficient removal of a 3’-matched nucleotide by APE1 3’-5’ exonuclease
activity. However, APE1 removed the 3’-mismatched T much more efficiently than it
removed a 3’-matched C (Figure 2.4, lanes 12-15 and 7-10). For all the substrates with a
T/G mismatch, APE1 mainly removed one nucleotide from the upstream primer containing
a 3’-mismatched T. Thus, APE1 3’-5’ exonuclease efficiently removed the 3’-mismatched
T. Interestingly, we found that APE1 3’-5’ exonuclease exhibited much weaker activity in
removing the 3’-mismatched T located next to a template T than in removing the
mismatched nucleotide next to a C on the template strand (Figure 2.4, lanes 7-10),
indicating that simultaneous demethylation of 5mCs on both the damaged and template
strands also decreased APE1 3’-5’ exonuclease activity.
3.5 FEN1 cleaves a sugar phosphate flap adjacent to a 3’-T/G mismatch
To further determine whether a 3'-terminus mismatched T will have any effect on
FEN1 cleavage, we characterized FEN1 cleavage activity with the substrates (25 nM)
containing an upstream 3’-C or 3’-T and a downstream 5’-THF residue and a template C
or T in the absence and presence of pol β. We found that in the absence of pol β, FEN1 (5
nM, 10 nM and 25 nM) exhibited poor cleavage activity in removing the 5’-THF flap
(Figure 2.5, lanes 2-4, 9-11 and 16-18), indicating inefficient removal of a 5’-THF flap
adjacent to a one-nucleotide gap by FEN1. In the presence of pol β DNA synthesis, FEN1
cleavage of the substrate with a 3’-matched C resulted in an increased amount of smaller
products resulting from FEN1 cleavage of a longer flap (Figure 2.5, lanes 5-7), indicating
that pol β strand-displacement synthesis created a longer flap for FEN1 cleavage.
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However, the presence of pol β DNA synthesis did not significantly improve FEN1
flap cleavage on the substrate with a 3'-mismatched T (Figure 2.5, lanes 12-14 and 19-21).
This indicated that FEN1 cleavage of a flap next to a 3’-mismatched T was inhibited even
in the presence of pol β. This appeared to result from the inhibition of pol β stranddisplacement synthesis by a 3’-T/G mismatch (Figure 2.3).
3.6 The efficiency of pol β extension of a 3’-mismatched T and APE1 3’-5’ exonuclease
to remove the 3’-mismatched T
Since our previous results indicate that removal of a 3’-mismatched T by APE1 is
critical for improving pol β fidelity, we then asked if APE1 could remove a 3’-mismatch T
before pol β could extend the mismatched nucleotide during BER. We tested this by
examining the efficiency of pol β DNA synthesis at 5 nM and that of APE1 3'-5'
exonuclease activity at 5 nM, 50 nM and 100 nM using the substrate containing a 3’mismatched T and a 5’-THF residue with a template C opposite the THF residue. The
enzymatic reaction products were measured at different time intervals ranging from 0 min
to 30 min. The percentage of products was plotted against time (Figure 2.6). The results
revealed that 5 nM pol β extended a 3'-mismatched T much more efficiently than APE1 3’5’ exonuclease removed the mismatched nucleotide at the same concentration. However,
the 3’-5’ exonuclease activity of APE1 at 50 nM and 100 nM removed the mismatched T
much more efficiently than 5 nM pol β extended the mismatched nucleotide (Figure 2.6).
This indicated that a high concentration of APE1 was sufficient to combat pol β extension
of a mismatched nucleotide. Since APE1 is much more abundant than pol β in mammalian
cells, the results further suggest that APE1 can remove a mismatched T before it is extended
by pol β in cells.
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3.7 BER can occur in the presence of 3’-T/G mismatch

	
  

Figure 2.4 APE1 3’–5’exonuclease activity removes a 3’-terminus mismatched T in a
CpG dinucleotide. APE1 3’–5’ exonuclease activity in removing a 3’-mismatched T in a
CpG dinucleotide was measured as described in “Materials and methods”. Substrates were
32
P-labeled at the 5’-end of the damaged strand. Lanes 1, 6 and11 correspond to the substrate
only. Lanes 2, 7 and 12 correspond to reaction mixtures with 5 nM APE1. Lanes 3, 8 and 13
correspond to reaction mixtures with 10 nM APE1. Lanes 4, 9 and 14 correspond to reaction
mixtures with 25 nM APE1. Lanes 5, 10 and 15 correspond to reaction mixtures with 50 nM
APE1. Substrates and APE1 cleavage products are indicated. Substrates are illustrated
schematically above the gel. The quantification of the APE1 3’–5’ exonuclease cleavage
products are shown below the gels.

	
  
To examine whether a 3’ T/G mismatch can ultimately result in the production of
BER products, we reconstituted BER by incubating the substrates without or with a T/G
mismatch with APE1, pol β, FEN1 and LIG I. We found that a significant amount of repair
products were produced during BER with a 3'-mismatched T in the absence of APE1
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(Figure 2.7A, lanes 6 and 10) although the amount of products was less than those formed

	
  

Figure 2.5 FEN1 flap cleavage in the presence of a T/G mismatch in a CpG dinucleotide.
FEN1 flap cleavage activity in the presence of a T/G mismatch in a CpG dinucleotide was
examined as described in “Materials and methods”. Substrates were 32P-labeled at the 3’-end of
the damaged strand. Lanes 1, 8 and 15 correspond to the substrate only. Lanes 2, 9 and 16
correspond to reaction mixtures with 5 nM FEN1. Lanes 3, 10 and 17 correspond to reaction
mixtures with 10 nM FEN1. Lanes 4, 11 and18 correspond to reaction mixtures with 25 nM
FEN1. Lanes 5, 12 and 19 correspond to reaction mixtures that contained 5 nM FEN1 in the
presence of 5 nM pol β. Lanes 6, 13 and 20 represent reaction mixtures that contained 10 nM
FEN1 in the presence of 5 nM pol β. Lanes 7, 14 and 21 represent reaction mixtures that
contained 25 nM FEN1in the presence of 5 nM pol β. Substrates and FEN1 cleavage products
are indicated. Substrates are illustrated schematically above the gel.

	
  
from the substrate with a 3'-matched C (Figure 2.7A, lane 2). This indicated that in the
absence of APE1, pol β extended a 3'-mismatched T resulting in repair product with a T/G
mismatch. We found that presence of high concentrations of APE1 (50 nM and 100 nM)
significantly stimulated the production of repair products (Figure 2.7A, lanes 7-8) during
BER with the substrate containing a 3'-mismatched T and a template C. However, this
effect was not evident with the substrate containing a 3'-mismatched T and a template T
(Figure 2.7A, lanes 11-12). This indicated that BER was accomplished through pol β
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tolerance of a 3'-mismatched T suggesting that this can further result in a C to T mutation,
and APE1 may reduce the production of the mutation.
3.8 APE1 significantly reduces C to T mutations resulting from a T/G mismatch
during BER
To further confirm whether APE1 can reduce mutations resulting from extension
of a 3’-mismatched T by pol β during BER, we sequenced the repair products generated
from reconstituted BER with the substrates containing a 3’-mismatched T adjacent to a
THF residue opposite a template C or T in the absence and presence of APE1. The results
showed that in the absence of APE1, all repair products (100%) contained a mismatched T
(Figure 2.7B). This indicated that the mismatched T was fully extended by pol β during
BER. However, in the presence of 50 nM APE1, only 7.7%-13% of the repair products
contained a mismatched T, and 87%-92.3% of the mismatched Ts were converted into
matched Cs (Figure 2.7B). This indicated that APE1 3’-5’ exonuclease activity efficiently
removed mismatched Ts allowing pol β to insert a C to base pair with a template G during
BER. Taken together, our results indicated that APE1 3’-5’ exonuclease significantly
reduced T/G mismatches, thereby preventing mutations in CpG dinucleotides during BER.
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Figure 2.6 The activities of pol β DNA synthesis and APE1 3’–5’ exonuclease in the context
of a T/G mismatch in a CpG dinucleotide. The activities of pol β and APE1 in extending or
removing a 3’-terminus mismatched T were determined at various time intervals (1, 2, 5, 10, 15
and 30 min) with a substrate containing a 3’-terminus mismatched T in a CpG dinucleotide with
a THF residue preincised by APE1 as described in “Materials and methods”. The amount of
products resulting from pol βDNA synthesis or APE1 3’–5’ exonuclease activity were
quantified by using Quantity One Software (Bio-Rad Laboratories, Hercules, CA). The
percentage of products was calculated as the amount of products over total amount of substrates
and was plotted against time.

	
  
4. DISCUSSION
In this study, for the first time, we explored the role of BER in maintaining the
integrity of CpG islands by removing a mismatched base when DNA base damage occurs
next to a T/G mismatch resulting from deamination of a 5mC in a CpG dinucleotide. Since
CpGs are susceptible to oxidative DNA damage, a DNA base lesion such as 8-oxoG or an
abasic site can be readily generated next to a T/G mismatch. In this scenario, both the
mismatched T and base lesion need to be resolved by the BER pathway. Thus an important
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Figure 2.7 BER reconstitution in the context of a T/G mismatch in a CpG dinucleotide.
(A) BER reconstitution in the context of a T/G mismatch was performed as described in
“Materials and Methods”. Substrates, were 32P-labeled at the 5’-end of the damaged strand.
Lanes 1, 5 and 9 correspond to substrate only. Lanes 2, 6 and 10 correspond to reaction
mixtures that contained 5 nM pol β, 50 nM FEN1 and 5 nM LIG I. Lanes 3, 7 and 11
correspond to reaction mixtures that contained 50 nM APE1, 5 nM pol β, 50 nM FEN1 and 5
nM LIG I. Lanes 4, 8 and 12 correspond to reaction mixtures that contained 100 nM APE1, 5
nM pol β, 50 nM FEN1 and 5 nM LIGI. Substrates and repair products are indicated.
Substrates are illustrated schematically above the gel. (B) DNA sequencing results of repair
products resulting from BER of a T/G mismatch and abasic lesion in a CpG dinucleotide.
Repair products were separated from the template strand with avidin beads. Subsequently,
repair products were amplified by PCR and cloned into a TA vector and subjected to DNA
sequencing. The percentage of repair products that contained a mismatched T or matched C
from the different substrates are shown.	
  

	
  
issue is how BER, in the context of the two different types of base lesions, may be initiated.
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It has been shown that OGG1 removes an 8-oxoG next to a 5’-T/G mismatch about 3.5fold faster than TDG removes the mismatched T (Sassa et al., 2014). This indicates that
the 8-oxoG is usually removed by OGG1 prior to the removal of the mismatched T by TDG.
This results in an abasic site next to the 5’-T/G mismatch. Surprisingly, we found that the
activity of TDG of removing the mismatched T adjacent to an abasic site was completely
inhibited by the abasic lesion (Figure 2.1, lanes 6-8) indicating that an abasic lesion next
to the mismatched nucleotide completely suppressed the removal of the mismatched T by
TDG. However, we showed that APE1 incised an abasic lesion efficiently in the presence
of the mismatched T (Figure 2.2, lanes 3-6 and lanes 9-12) leading to the production of a
single-strand break intermediate with the 3'-terminus mismatched T. We found that pol β
efficiently extended the 3’-mismatched T (Figure 2.3, lanes 6-8 and lanes 10-12), thereby
resulting in maintenance of the mismatched base in the repair products (Figure 2.7A, lanes
6-8 and lanes 10-12). This subsequently led to a C to T transition mutation in the repair
products (Figure 2.7B). However, the pol β-mediated mutagenic effect was significantly
reduced (Figure 2.7B) through the removal of the 3’-mismatched T by APE1 3’-5’
exonuclease activity (Figure 2.4, lanes 7-10 and lanes 12-15 and Figure 6). Our results
support a model whereby a base lesion such as an abasic lesion occurs adjacent to a T/G
mismatched basepair in a CpG dinucleotide during DNA demethylation. Removal of the
mismatched T by TDG is completely inhibited by the abasic lesion. This allows APE1 to
incise the abasic site at its 5'-end to initiate BER. This subsequently
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Figure 2.8 APE1 3’–5’ exonuclease combats the extension of a T/G mismatch by pol β and
C to T mutations in CpGs during BER. During active DNA demethylation of 5mC in CpG
dinucleotides, the 5mC is deaminated to T thereby leading to production of a T/G mismatch,
while the adjacent G can also be damaged by oxidative stress resulting in an abasic lesion. TDG
activity in removing the T/G mismatch is completely inhibited by the abasic lesion. This allows
the accumulation of T/G mismatches that are adjacent to abasic lesions. APE1 can efficiently
incise the resulting abasic site, leading to a 1nt gap with a 3’-terminus mismatched T. Pol β can
extend the mismatched T to create a short flap with a sugar phosphate. Subsequently,
FEN1removes the flap, generating a nick for ligation by DNA ligase I. This leads to a C to T
transition mutation (Sub-pathway 1). In a scenario where the 3’-terminus mismatched T is
efficiently removed by APE1 3’–5’ exonuclease prior to polβ extension of the mismatch
nucleotide, pol β incorporates a C to base pair with a template G. This prevents a C to T mutation
(Sub-pathway 2).	
  

leads to a 1nt gapped DNA with a 3'-mismatched T that can be subjected to two different
subpathways (Figure 2.8). If the 3'-mismatched T is captured by pol β before it is removed
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by APE1 3’-5’ exonuclease activity, it is extended by pol β. This then results in the
sustainment of the 3'-mismatched T during BER, thereby causing a C to T transition
mutation (Figure 2.8, subpathway 1). However, if the 3'-mismatched T is removed by
APE1 3'-5' exonuclease activity before it is extended by pol β, pol β fills in the gap by
incorporating a correct nucleotide to accomplish BER (Figure 2.8, subpathway 2). In this
scenario, APE1 3'-5' exonuclease activity prevents mutation during BER in the context of
a T/G mismtach DNA demethylation intermediate.
Here, we provided the first evidence that APE1 3’-5’ exonuclease can prevent C to
T mutations during BER of an abasic lesion adjacent to a T/G mismatch in a CpG
dinucleotide, thereby maintaining the integrity of CpGs. APE1 3’-5’ exonuclease activity
was initially reported to be able to remove a 3’-mismatched nucleotide in DNA (Chou and
Cheng, 2002). It has been found that the efficiency of the 3’-5’ exonuclease in removing a
mismatched nucleotide is 160-fold higher than that in removing a matched nucleotide
(Chou and Cheng, 2002). Thus, it has been proposed that APE1 3’-5’ exonuclease serves
as a proofreading enzyme for correcting mismatched nucleotides incorporated by pol β.
This is further suggested by a previous finding showing that APE1 forms a complex with
pol β on a nicked or 1 nt gapped DNA with a deoxyribonucleotide phosphate (dRP) flap
(Liu et al., 2007b). Although the APE1-pol β-DNA ternary complex failed to significantly
stimulate APE1 3’-5’ exonuclease activity on the nicked DNA (Liu et al., 2007b), it is
possible that the complex may facilitate APE1 3’-5’ exonuclease activity at a gapped DNA
with a sugar phosphate. Moreover, our results showed that high concentrations of APE1
removed the 3’-mismatched T more efficiently than pol β extension of the 3’-mismatched
nucleotide. Thus, it is conceivable that a relatively high concentration of APE1 in
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mammalian cells exhibits a robust 3’-5’ exonuclease activity that can cooperate with pol β
to remove a T/G mismatch in CpGs and ensure that the polymerase inserts a correct
nucleotide. Thus, sufficient amounts of APE1 in mammalian cells should lead to
prevention of C to T transition mutations resulting from DNA demethylation during BER,
thereby sustaining epigenome stability.
Our results showed that pol β efficiently extended a mismatched T basepaired with a
template G that is adjacent to a single-nucleotide gap. This is consistent with the findings
from a study from the Wilson group (Sassa et al., 2012). A study from the Sweasy group
has shown that pol β exhibits low fidelity in gap-filling and strand displacement synthesis
(Shah et al., 2003). Pol β can extend a T basepaired with a G adjacent to a 6 nt gap, albeit
with a low efficiency compared with extension of a matched C (Shah et al., 2003). All these
findings indicate that pol β can tolerate a 3’-terminus mismatch next to a single-nucleotide
gap. A translesion synthesis polymerase, pol κ, has been found to extend a 3’-mismatched
T via a primer-template misalignment or direct extension (Wolfle et al., 2003). However,
our results showed that pol β could extend a mismatched T only by direct extension,
suggesting that pol β interacted with the 3’-mismatched T and the template strand in a more
rigid manner than pol κ.
Our study has also provided new insight into a mechanism underlying mutations in
CGIs that can be readily generated through BER and BER-mediated DNA demethylation.
We have demonstrated that in the scenario where 3’-mismatched T is adjacent to an abasic
site in a CpG dinucleotide, the mismatched T was efficiently removed by APE1 before pol
β extended it (Figure 2.7B), and a C to T mutation was prevented (Figure 2.7B). However,
in the scenario where a T occurs at the template strand and is opposite an abasic site
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(Figures 2.2-2.5 and Figure 2.7), the T could not be removed by APE1 3’-5’ exonuclease.
Instead, pol β filled in the gap by inserting an A to basepair with the template T leading to
a C to T transition. Thus, in this scenario, C to T mutations cannot be prevented by APE1
3’-5’ exonuclease. Our discoveries provide new mechanistic evidence underlying the high
frequency of mutations at CGIs. In conclusion, our study demonstrates that APE1
exonuclease activity functions as a proofreader for pol β to sustain the integrity of CGIs
during BER and DNA demethylation by removing a 3'-terminus T/G mismatch.
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CHAPTER 3
ENVIRONMENTALLY-INDUCED OXIDATIVE DNA DAMAGE DISRUPTS DNA
METHYLATION PATTERN IN HUMAN BREAST CANCER 1 (BRCA1) GENE VIA
BASE EXCISION REPAIR
ABSTRACT
Mutations of breast cancer 1 (BRCA1) gene have been shown to play a crucial role
in breast cancer development. Yet, downregulation of BRCA1 expression has commonly
been observed in breast cancer cells, and this may result from disruption of DNA
methylation pattern in the promoter region of the gene. We examined the effects of
environmentally induced oxidative DNA damage on the DNA methylation pattern of
BRCA1 gene with bisulfite DNA sequencing. We discovered that environmental oxidative
DNA damaging agents, bromate and chromate disrupt DNA methylation pattern at CpG
dinucleotides in the BRCA1 gene that range from -189 to +27 in human cells. We found
that bromate and chromate resulted in the demethylation of the 5-methylcytosine (5mC) in
the CpGs at the sites of -189, -134, -29, -19, +16, +19. Surprisingly, we found that the
DNA damaging agents created a series of new DNA methylation sites at the CpGs located
at the sites of -80, -55, +8, +27 in BRCA1 gene. We showed that bromate and chromateinduced demethylation of 5mC at the CpGs was mediated through deletion of cytosines
and base substitutions via BER, and this was accomplished by nucleotide misinsertion of
pol β on the CpGs. Moreover, we identified an interaction between DNA polymerase β
with DNA methyltransferase 1 in cells. Our results indicate that bromate and chromate alter
DNA methylation pattern in the promoter and transcribed region of BRCA1 gene via
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oxidative DNA damage. We further suggest that BER crosstalks with DNA
methyltransferases to induce additional DNA methylation sites.
1.  INTRODUCTION
Methylation of DNA is associated with important biological functions including
silencing of retrovirus, gene expression, genomic imprinting, X-chromosome inactivation,
embryonic development, genomic instability, cancer development, among others (Bird,
1992, 2002; Ehrlich, 2005; Kass et al., 1997; Smith and Meissner, 2013). In mammalian
cells, 60~90% of cytosines in CpG dinucleotide clusters are methylated at its 5-carbon
(Ehrlich et al., 1982). Unmethylated CpG dinucleotide clusters usually locate at the
promoter (the upstream) regions of the genes in a tissue-specific manner. A normal DNA
methylation pattern at a specific gene is maintained upon the balance between DNA
methylation and demethylation, and the underlying mechanisms remain to be elucidated
(Niehrs, 2009). While DNA methylation can be modulated by the activities of DNA
methylation transferases and supplies of the methylation cofactor S-adenomethionine
(SAM), in general, DNA demethylation is mediated by both passive and active pathways
in mammalian cells (Gong and Zhu, 2011) and can be modulated by the inhibition of the
activities of methyltransferases as well as altered activities of BER enzymes and their
coordination. Since Cs and Gs in CpGs form hotspots of oxidative DNA base damage and
mutations (Lutsenko and Bhagwat, 1999), DNA base lesions can directly lead to
deamination of 5mCs resulting in loss of the methylated Cs through BER leading to
substitution of a C with other nucleotides and mutations. In addition, a base lesion that
occurs on CpGs and the adjacent regions may also affect the activity of DNMTs and even
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inhibit their activities. All these can lead to passive loss of a 5mC, thereby disrupting a
normal DNA methylation pattern. 	
  
The Environmental toxicant Chromium, Cr (VI) has been reported to be associated
with lung cancer (Zhou et al., 2009). The Cr (VI) can also alter the DNA methylation
pattern and histone modifications, thereby activating or suppressing gene expression. This
may lead to carcinogenesis (Salnikow and Zhitkovich, 2008; Sun et al., 2009; Zhou et al.,
2009). Bromate, on the other hand, is an environmental pollutant that can be generated
during water disinfection and beverage fermentation (Ballmaier and Epe, 2006). Bromate
can induce oxidative DNA damage such as 8-oxoGs (Kawanishi and Murata, 2006) at
CpGs that may in turn inhibit the activities of DNMTs causing loss of 5mCs. Since BER
mediates active DNA demethylation while it repairs DNA base lesions at CpGs
simultaneously, BER may result in mutations via nucleotide misinsertions by pol b during
these processes because of a low fidelity of DNA synthesis of the DNA polymerase (Jiang
et al., 2015). This can also lead to loss of 5mCs and passive DNA demethylation. Thus,
DNA base lesions can modulate DNA methylation patterns through different mechanisms.
As one of the most prevalent cancers among American women, breast cancer has
been shown to be associated with mutations in the tumor suppressor genes, BRCA1 and
BRCA2 (Bosviel et al., 2012; Miki et al., 1994; Wooster et al., 1995). However, recent
studies have demonstrated that more than 90% of breast cancer cases do not have a
BRCA1/2 mutation (sporadic breast cancer). However, downregulation of BRCA1 gene
expression has been found to be associated with sporadic tumor development (Bosviel et
al., 2012; Dobrovic and Simpfendorfer, 1997; Esteller et al., 2000). It appears that the DNA
hypermethylation at the promoter of the BRCA1 gene may play a critical role for
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suppressing of the gene expression in sporadic breast cancer (Esteller et al., 2000; Herman
and Baylin, 2003; Jones and Baylin, 2007; Matros et al., 2005; Rice et al., 1998; Rice et
al., 2000; Wei et al., 2005). On the basis of these studies, we hypothesized that the
environmental toxicants, bromate and chromate, can cause DNA base lesions in the
BRCA1 promoter as well as the encoding region of BRCA1 protein, and this then initiates
BER that may subsequently modulate DNA methylation pattern at the BRCA1 gene. This
may then result in downregulation of BRCA1 gene expression, leading to development of
breast cancer. To test this hypothesis, in this study, we examined the effects of bromate
and chromate on the DNA methylation pattern of BRCA1 gene in human embryonic kidney
293 (HEK293) cells treated with different concentrations of the environmental toxicants
using bisulfite DNA sequencing. We found that bromate and chromate not only altered the
DNA methylation pattern at the BRCA1 gene, but also caused mutations in the gene. We
found that bromate and chromate resulted in the loss of 5mCs as well as C to G and C to A
mutations at several CpGs of the BRCA1 gene. We further demonstrated that the mutations
were caused by pol β nucleotide misinsertion during its synthesis in bypassing a base
lesion, 8-oxoG located at the template strand. This was further supported by the fact that
pol b was recruited to DNA damaging sites induced by bromate and chromate in HEK293
cells. Surprisingly, we found that bromate and chromate also induced additional DNA
methylation sites at the BRCA1 gene, and pol β interacted with DNMT1. This suggests
that pol β recruited DNMT1 to the sites that surround a DNA base lesion. This may
stimulate DNA methylation by DNMT1 at the sites adjacent to the damaging sites. Our
study provides new insights into the molecular mechanisms underlying oxidative DNA
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damage induced alterations of DNA methylation at BRCA1 gene and its effects on
epigenetic changes of the BRCA1 gene and its expression.
2. MATERIALS AND METHODS
2.1 Materials
Human embryonic kidney (HEK) cells were purchased from Life Technologies
(Carlsbad, CA, USA). The fetus bovine serum (FBS), RPMI 1640 and Dulbecco’s
Modified Eagle’s Medium (DMEM) cell culture medium were purchased from Thermo
Fisher Scientific (Waltham, MA, USA). The genomic DNA isolation kit was purchased
from Promega (Agora, WI, USA). The Lightning Bisulfite Conversion kit was purchased
from ZYMO Research (Irvine, CA, USA). The Dream Taq polymerase master mix and the
Original TA Cloning kit were purchased from Invitrogen (Carlsbad, CA, USA). The Rapid
DNA Ligation kit was purchased from Thermo Scientific (Carlsbad, CA, USA), and the
BigDye kit for sequencing was purchased from Applied Biosystems (Austin, TX, USA).
The DNA oligonucleotides containing an 8-oxoguanine were synthesized by the
Midland Certified Reagent Company Inc. (Midland, TX, USA). All other oligonucleotides
were synthesized by Integrated DNA Technologies (IDT, Coralville, IA, USA).
Deoxynucleoside 5’-triphosphates (dNTPs) were purchased from Sigma-Aldrich (St.
Louis, MO, USA). Radionuleotides, [γ-32P] ATP (6000 mCi/mmol) and cordycepin 5’triphosphate 3’-[α-32P] (5000 mCi/mmol) were purchased from MP Biomedicals (Santa
Ana, CA, USA). Micro Bio-Spin 6 chromatography columns were from Bio-Rad
(Hercules, CA, USA). All other standard chemical reagents were purchased from Thermo
Fisher Scientific (Pittsburgh, PA, USA) and Sigma-Aldrich (St. Louis, MO, USA). Pol β
were purified by FPLC as described previously (Liu et al., 2005). The pol β expression
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plasmid was a generous gift from Dr. Samuel H. Wilson at the National Institute of
Environmental Health Sciences (NIEHS)/National Institutes of Health, Research Triangle
Park, North Carolina.
Polyclonal anti-pol b primary antibody (ab26343), monoclonal anti-pol b primary
antibody (ab175197), polyclonal anti-DNMT1 primary antibody (ab19905), and
monoclonal anti-DNMT1 primary antibody (ab188453) were purchased from Abcam
(Cambridge, MA, USA). Pierce protease inhibitor tablets (B2162578) and protein A
agarose beads were purchased from Thermo Scientific (Waltham, MA, USA). The LI-COR
C-DiGit Chemiluminescence Western Blot Scanner (Model: 3600) for western blot was
purchased from LI-COR Biotechnology (Lincoln, NE, USA)
2.2 Oligonucleotide substrates
Substrates containing a 76-nt template strand with an 8-oxoG or THF at the 39th
Table 3.1 Sequences of the oligonucleotide substrates
Downstream nt Seq. 5’-3’
strand
D1
37 pGAGCTCACGCCGCGCAGTCGCAGTTTTAATTTATCTG
D2
37 pFGAGCTCACGCCGCGCAGTCGCAGTTTTAATTTATCTG
Template
strand
T1
76 CAGATAAATTAAAACTGCGACTGCGCGGCGTGAGCTCG
CTGAGACTTCCTGGACGGGGGACAGGCTGTGGGGTTTC
T2
76 CAGATAAATTAAAACTGCGACTGCGCGGCGTGAGCTC(8oxoG)
CTGAGACTTCCTGGACGGGGGACAGGCTGTGGGGTTTC
Upstream
strand
U1
38 GAAACCCCACAGCCTGTCCCCCGTCCAGGAAGTCTCAG
	
  
	
  
nucleotide
counted from the 5’-end were designed to mimic a DNA base lesion generated
after the genome is damaged oxidative DNA damaging agent. Substrates mimicking the
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intermediates with a 1-nt gap opposite a template 8-oxoG formed during DNA lagging
strand synthesis and BER, were constructed by annealing the 38-nt upstream primer and a
37-nt downstream primer with a 5’-phosphate or 5’-THF residue with the template strand
containing a G or 8-oxoG at a molar ratio of 1:2:2. Substrates were radiolabeled at the 5’end of the upstream primers for measuring the activities of different enzymes. The
sequences of the oligonucleotide substrates are listed in Table 3.1.
2.3 Treatment of HEK293 cells by bromate and chromate
The HEK293 cells were grown in DMEM with 10% FBS to near confluence. Cells
were then exposed to 5 mM bromate or 10 µM of chromate for 24 hours. Cells were washed
by PBS twice and supplied with the whole medium (10% FBS) for additional 24 to 48
hours for recovery and DNA damage repair. Cells were then harvested, and the genomic
DNA was isolated according to the protocol provided by the Promega genomic DNA
isolation kit. Genomic DNA was then subject to bisulfite conversion with Bisulfite
Lightning Conversion kit purchased from ZYMO Research. The DNA fragments in
BRCA1 gene were amplified. The bisulfite PCR reactions were set up by using the primers
shown in Table 3.2.
Table 3.2 Primers for bisulfite sequencing
Sense
nt
Seq. 5’-3’
strand
GAGGCTAGAGGGCAGGCACTTTATGGCAAACTCAGG
Forward
36
GTCCCCCGTCCAGGAAGTCTCAGCG
Reverse
25
Anti-sense
strand
TTTTAGAATAYGAAATTAAGGTATAATTAGAGGATGGG
Forward
38
CAATAAACCRCAACTAAAAAAATAAAAACTAAAAAAC
Reverse
37
Y: either C/T; R: either G/A

87	
  

2.4 Recruitment of pol β to DNA damage sites
The HEK293 cells were grown in DMEM with 10% FBS to 70~80% confluence.
Cells were then transfected with a plasmid that expresses a green fluorescence protein
tagged human pol β (GFP-hPol β) 24 hours. Cells were then seeded in a chamber slide and
grown for 24 hours. Cells were subsequently treated with 5 mM bromate or 10 µM
chromate for 1 h and fixed with 4% paraformaldehyde. Cells were washed twice by ice
cold PBS and stained by mounting media containing 1% of DAPI and were imaged with
the Olympus Laser Confocal Microscope (FIU Confocal Microscopy Facilities).
2.5 Pol β DNA synthesis in bypassing an 8-oxoG
In vitro pol β DNA synthesis in bypassing an 8-oxoG on the template strand that is
opposite the C at -166 nt of the BRCA1 promoter was performed by incubating purified
human pol β with the substrates bearing aG or an 8-oxoG opposite the C at -166 nt strand
that is complementary to the strand ranging from -189 to -80 nt of the BRCA1 promoter.
Various concentrations of pol β and substrates were incubated in BER reaction buffer with
5 mM MgCl2, and 50 µM dNTPs in 10-µL reaction mixture. Reaction mixtures were
incubated at 37oC for 30 min. Reactions were terminated with 2x stopping buffer that
contains 95% formamide and 10 mM EDTA followed by incubation at 95oC for 5 min. All
substrates were 32P-labeled at the 5’-end of the upstream strand. Substrates and products
were separated with 15% or 18% urea-denaturing PAGE gel and were detected with the
Pharos FX Plus PhosphorImager (Bio-Rad, Hercules, CA, USA)
2.6 Pol β nucleotide misinsertion	
  
In vitro pol β misinsertion activity was performed by incubating various
concentrations of pol β with the substrates containing a normal G or 8-oxoG on the
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template. The 10-µL reaction was assembled with the substrates and different
concentrations of pol β in BER reaction buffer with 5 mM MgCl2 and 50 µM dA or dT or
dG or dC, respectively. Reaction mixtures were assembled on ice and incubated at 37oC
for 30 min. Reactions were terminated by addition of 2 × stopping buffer containing 95%
formamide and 10 mM EDTA and incubation at 95% for 5 min. Substrates and products
were then separated by 15% or 18% urea-denaturing PAGE gel and detected with Pharos
FX Plus PhosphorImager. All substrates were

32

P labeled at the 5’-end of the upstream

primers.
2.7 Pol β-DNMT1 interaction detected by co-immunoprecipitation (Co-IP) to detect
in HEK293 cells after bromate/chromate exposure
The interaction been DNMT1 and pol β was examined by employing Co-IP assay.
The HEK293 cells were treated with 10 µM chromate for 24 hours with or without 24 hours
of recovery. Cells were harvested in cold PBS buffer, then resuspended in cold lysis buffer
with 0.1% NP40 with protease inhibitors (Thermo Scientific, Waltham, MA, USA). 20 µL
of cell lysate was taken and set aside as an input. 800 ng of cell lysate was precleared with
20 µL of protein A agarose beads (Thermo Scientific, Waltham, MA, USA) (50% protein
A agarose at a ratio of 100 µL for a 1 mL lysate) for 30 min at 4oC. The amount of total
protein of cell lysate was determined with Bradford assay. Cell lysate was then diluted with
PBS to the total protein of 5 µg/µL. Seventy five microliters cell lysate was incubated with
3 µL of polyclonal anti-pol b primary antibody (Abcam, Cat. No. ab26343, Cambridge,
MA) at 4 oC overnight. Cell lysate was then incubated with 100 µL 50% protein A agarose
beads at 4oC with rotation for 2 hours and subject to centrifugation at 14,000 g for 1 min
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at 4oC for agarose bead precipitation. The beads were washed 3 times with wash buffer
containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 1% NP-40 and 2 mM EDTA. 	
  Protein
complexes precipitated with the antibody were eluted in SDS-loading buffer with heating
at 50 oC for 10 mins. Individual proteins in the precipitated protein complexes were then
subjected to SDS-PAGE and immunoblotting with monoclonal anti-pol b antibody
(1:2000, ab175197, Abcam) and monoclonal anti-DNMT1 primary antibody (1:2000,
ab188453, Abcam). Western Sure Premium secondary antibody (1:2000, 926-80011, LICOR) was employed for detecting the proteins with measurement of chemiluminescence
that was detected by LI-COR C-DiGit scanner.

3. RESULTS
3.1 Bromate and chromate treatment altered DNA methylation pattern on BRCA1
gene
Since bromate and chromate-induced oxidative DNA damage can change the
DNA methylation pattern and histone post-translational modifications by targeting Cs,
5mCs and Gs on CpGs, it is conceivable that these toxicants can also cause oxidized
bases on CpGs at BRCA1 gene and subsequently the loss of 5mCs and point mutations,
thereby affecting activation and/or repression of BRCA1 gene expression as well as
breast cancer development. To test this, we initially determined the DNA methylation
pattern on the promoter and encoding region of BRCA1 gene in untreated HEK293 cells
and HEK293 cells treated with bromate and chromate using bisulfite DNA sequencing
(Figures 3.1A and 3.2A). The results showed that in the promoter region of BRCA1 gene
of untreated cells, the CpGs located at -189, -134, -29, -19, +16, and +19 on the sense
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strand of the gene are partially methylated (Figures 3.1A and 3.2A). On the antisense
strand, the CpGs located at -189, and -80 are partially methylated (Figure 3.2A).
However, cellular treatment of 5 mM bromate for 24 h led to the formation of additional
methylation sites at the CpGs located at -80, -55, -21, and +8 (Figures 3.1B and 3.2B).
The treatment also resulted in the loss of methylation at -189, -134, +16 and +19 (Figures
3.1B and 3.2B). Chromate treatment at 10 µM led to the formation of new methylation
sites at -80, -55, and +27 while it resulted in loss of DNA methylation at -189, -29, -19,
+16, and +19 (Figures 3.1C and 3.2C).

91	
  

	
  
	
  

Figure 3.1. The DNA methylation pattern on BRCA1 promoter from -189 to +27 in HEK293 cells with and without bromate and
chromate treatment. Bromate treatment resulted in the loss of methylation at CpGs located at -189 and -134 and gain of methylation at
CpGs at -80, -55, -21 and +8. Chromate treatment led to the loss of methylation at -189, -29, -19, +16 and +19 and gain of at CpGs at -80, 55 and +27.
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Figure 3.2 The DNA methylation pattern on BRCA1 gene promoter and encoding region
from -189 to +27 in HEK293 cells with or without treatment of bromate and chromate.

	
  
	
  
	
  
	
  
Bromate
and chromate treatment caused the loss of 5mCs at the CpGs located at -34 and
+16 via mutations. Further mutation analysis showed that bromate treatment resulted in C
to A mutation (Figure 3.3B), whereas chromate treatment mainly led to C to G mutation at
-189, -173, -166, and -127, (Figure 3.3A). The mutation spectrum showed that the major
mutations induced by bromate and chromate on the BRCA1 gene is C to G mutation
(Figure 3.3).
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Figure 3.3 The mutation spectrum of BRCA1 gene in HEK293 cells induced by chromate
(A) and bromate (B) treatment.
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3.2 Pol β recruits to the DNA damage sites induced by bromate and chromate
To determine whether pol β can be recruited to bromate and chromate-induced DNA
damage sites in cells, we exposed HEK293 cells transfected with a plasmid expressing
GFP-tagged human pol β to 5 mM bromate. We found that GFP-pol β proteins were located
in the nucleus stained with DAPI (Figure 3.6 upper panel). Upon treatment of chromate,
the green loci of GFP-pol β formed in the nucleus of HEK293 cells. This indicates that
	
  

	
  
Figure 3.4 HEK293 cells transfected with GFP-pol β were treated with 10 µM
chromate for 1 hour. The green foci of pol β inside the nucleus pointed by the yellow
arrows. The HEK293 cells were transfected with a plasmid expressing GFP-tagged pol β
for 24 hours.
	
  

GFP-pol β was recruited to DNA damage induced by chromate (Figure 3.4, bottom panel).
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3.3 Pol β can bypass an 8-oxoG during DNA replication and BER through nucleotide
misinsertion.
Previous studies have shown that during DNA replication and BER, pol β exhibits
translesion synthesis activity to bypass a DNA base lesion (Bassett et al., 2002b; Chary et
al., 2012b; Hashim et al., 1997a; Hoffmann et al., 1996a; Maga et al., 2009a; Servant et al.,
2002a; Vaisman and Chaney, 2000a; Villani et al., 2011a). Pol β lesion bypass synthesis
can further induce a high frequency of mutations in the genome (Bassett et al., 2002a; Batra
et al., 2006; Beard et al., 2009; Beard and Wilson, 2014; Chary et al., 2012a; Efrati et al.,
1997; Hashim et al., 1997b; Hoffmann et al., 1996b; Servant et al., 2002b; Vaisman and
Chaney, 2000b). Furthermore, since pol β does not bear a 3’-5’ exonuclease activity for
proofreading, high levels of pol β may cause high mutation rates, and this is associated
with development of a variety of cancer cells (Canitrot et al., 2000; Scanlon et al., 1989;
Srivastava et al., 1999). Thus, it is possible that pol β was recruited to DNA damage
induced by bromate and chromate to bypass an 8-oxoG through its translesion synthesis
activity. To test this, we examined whether pol β can bypass an 8-oxoG through nucleotide
misinsertation to create a G:G mispair at the promoter region of BRCA1. This was
determined by incubating 20 nM purified pol β protein with the substrate without the
downstream strand (open template) and the gapped substrate that contained a template 8oxoG at CpG located at -166 of human BRCA1 promoter. The results showed that 20 nM
pol β inserted all four dNTP to base pair with the 8-oxoG on the open template substrate
(Figure 3.5A and 3.5, lanes 2, 3, 4 and 5) but with a higher efficiency in inserting dA and
dC (Figure 3.5, lanes 2 and 4). For the 1-nt gap-THF substrate containing an 8-oxoG, 20
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Figure 3.5 Pol β misincorporated nucleotides to bypass an 8-oxoG. Lanes 2, 7 and 12
correspond to reaction mixtures with 20 nM pol β (panel B) in the presence of 50 µM dA. Lanes
3, 8 and 13 correspond to reaction mixtures with 5 nM pol β (panel A) and 20 nM pol β (panel
B) in the presence of 50 µM dT. Lanes 4, 9, and 14 correspond to reaction mixtures with 20 nM
pol β (panel B) in the presence of 50 µM dC. Lanes 5, 10 and 15 correspond to reaction mixtures
with 20 nM pol β (panel B) in the presence of 50 µM dG. Substrates are illustrated schematically
above the gel.

	
  
nM pol β mainly inserted dA and dC when bypassing the lesion (Figure 3.5, lanes 12, 14).
It also inserted dT and dG with a relatively low efficiency in bypassing an 8-oxoG (Figure
3.5, lanes 13, 15). Interestingly, the results showed pol β preferentially to insert dG when
bypassing an 8-oxoG in the open template, 1-nt gap and 1-nt gap-THF substrates (Figure
3.5, lanes 5, 10, and 15). Furthermore, pol β exhibited a higher efficiency to insert dG when
bypassing an 8-oxoG in the 1-nt gap-THF substrate compared to the 1-nt gap substrate.
The results indicate that pol β misinserted dG to bypass an 8-oxoG lesion during BER in
CpGs. This is consistent with our results showing that bromate and chromate
predominantly induced a C to G mutation via a G:G mispair (Figures 3.1 and 3.2).
3.4 Pol β interacts with DNMT1 in HEK293 cells upon chromate treatment
Previous studies have shown that DNA repair proteins such as HR enzymes can
interact with DNMT3a, The BER enzyme TDG can also interact with DNMT3a alteration
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of DNA methylation pattern and gene transcription (Li et al., 2007; Russo et al., 2016).
Since our results showed that bromate and chromate induced additional DNA methylation
site at BRCA1 gene, this suggests a crosstalk between DNA damage, BER and DNMTs.
We then examined a possibility that pol β and DNMT1 may interact with each other in
cells with co-immunoprecipitation. We found that pol β and DNMT1 coimmunoprecipitated upon treatment of 10 µM chromate without recovery (Figure 3.6, lane
6) suggesting that pol β recruited DNMT to the region adjacent chromate-induced DNA
base lesions in cells. Interestingly, pol b exhibited little interaction with DNMT1 after 24
h recovery from chromate treatment (Figure 3.6, lane 7) suggesting that the two proteins
interacted immediately after DNA damage occurred at BRCA1 gene.

4. DISCUSSION
For the first time, we showed that environmental toxicants, bromate and chromate
altered the DNA methylation pattern of the BRCA1 gene by directly causing the loss of
5mCs, mutations and indirectly creating additional new 5mCs. We found that bromate- and
chromate-induced oxidative DNA damage resulted in the loss of 5mCs specifically on
CpGs located at -134, -29, -19 and +19 as well as point mutations on CpGs at -189 and +16
(Figure 3.2). We further demonstrated that bromate and chromate predominantly caused C
to G and C to A mutations (Figure 3.3), and this was mediated by pol b nucleotide
misinsertion in bypassing an 8-oxoG on the template strand (Figure 3.5). Surprisingly, we
discovered that bromate and chromate induced additional methylation on CpGs at -80, -55,
-21 and +8, which are adjacent to the sites with loss of 5mCs and point mutations (Figures
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3.1 and 3.2). We further identified an interaction between pol b and DNMT1 (Figure 3.6).
On the basis of the results, we propose a hypothetical model during which bromate and
chromate induce oxidative DNA base damage on the CpGs at the BRCA1 gene. Pol b is
then recruited to the lesions to perform its gap-filling synthesis. This subsequently leads to
loss of 5mCs via substitution of a 5mC with a C and mutations at the CpGs via pol bmediated nucleotide misinsertion for bypass of an 8-oxoG on the template strand.
Simultaneously, bromate- and chromate-induced base lesions induce the interaction
	
  

	
  

	
  

Figure 3.6 Chromate exposure resulted in the interaction between pol β and DNMT1.
Lane 1 represents molecular weight marker. Lanes 2-3 represent the input control. Lanes 45 illustrate the immunoprecipitates resulting from a pol b antibody. Lanes 6-7 represent the
immunoprecipitates resulting from a DNMT1 antibody. Lane 8 correspond to the IgG
control. Lanes 3, 5, 7 illustrate the samples obtained after 24 h recovery. Cells were treated
with 10 µM chromate for 24 h.

	
  
between pol b and DNMT1, which recruit DNMT1 to create additional methylated CpGs
at the BRCA gene (Figure 3.7).
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Figure 3.7 The hypothetical model for bromate and chromate to alter DNA
methylation pattern of the BRCA1 gene via DNA base lesions and BER in human
cells.

	
  

Previous studies showed that DNMT1, DNMT3a can interact with DNA repair

enzymes such as TDG, therefore alter DNA methylation pattern via DNA damage (Li et
al., 2007). Giusi Russo’s group has further demonstrated that DSBs also modulate DNA
methylation (Russo et al., 2016). However, the mechanisms and biological significance of
DNA damage-induced DNA methylation pattern change remain unknown. Since TDG
plays a critical role in mediating one of the subpathways of BER-mediated active DNA
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demethylation, the interaction between TDG and DNMTs suggests that the BER-mediated
active DNA demethylation coordinates with DNMTs to sustain the stability of DNA
methylation. Here, we provided the first evidence showing that a repair DNA polymerase,
pol b interacted DNMT1 to recruit it to the sites adjacent to a base lesion producing
additional 5mCs on the CpGs at BRCA1 gene. The results further suggest that DNA base
lesions can modulate DNA methylation pattern of BRCA1 gene by facilitating the
interactions between BER enzymes and DNMT1.
Recent studies have shown that oxidative DNA damage can induce the recruitment
of DNMT1 and DNMT3B and histone posttranslational modification enzymes to DNA
damaging sites, and this has been implicated in inflammation-induced tumorigenesis
(Maiuri et al., 2017; O'Hagan et al., 2011). It has been further shown that the mismatch
repair proteins, MSH2 and MSH2-MSH6 can be recruited to oxidative DNA damage to
recruit DNMT1 to the damaging sites causing DNA methylation pattern changes (Ding et
al., 2016; Maiuri et al., 2017). This indicates that mismatch repair proteins may mediate
the recruitment of DNMTs to DNA base lesions. Yet, it remains unknown if DNA repair
enzymes and proteins from the other DNA repair pathways can interact DNMTs and recruit
them to DNA damage sites. Here, we made the first discovery that the central component
of BER, pol b interacted with DNMT1 to modulate DNA methylation pattern in the
BRCA1 gene. Interestingly, we have recently found that MSH2-MSH3 can physically
interact with pol b in cells (Lai et al., 2016). Thus, it is possible that pol b may interact
with DNMT1 through MSH2 protein in cells.
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SUMMARY
DNA base excision repair (BER) is responsible for repairing DNA base lesions
such as alkylated, oxidized and deaminated bases as well as ssDNA breaks. Thus, it is an
essential repair pathway of maintaining genomic stability and integrity. Moreover, BER
plays a critical role in mediating active DNA demethylation thereby exhibiting a dual role
in DNA damage repair and regulation of DNA methylation. In addition, BER is also
involved in lesion bypass during DNA replication and repair particularly the bypass of
cyclodeoxynucleotides (cdPu) lesions that are resistant to DNA repair and readily
accumulate in the genome. In Chapter 1 of this dissertation, we explored the mechanisms
underlying bypass of cdA lesions by pol β during DNA replication and repair. We showed
that pol b knockout MEF cell extract failed to produce repair product via bypass of a RcdA or S-cdA lesion during BER indicating that pol b played a major role in bypassing
cdA lesions. We demonstrated that pol b bypassed a R-cdA by incorporating both correct
and incorrect nucleotides and failed to bypass a S-cdA lesion, thereby resulting in
accumulation of DNA strand breaks. This study identified a new role of pol b, the central
component of BER in bypassing cdPu lesions during DNA replication and BER. In Chapter
2, we explored the dual roles of key BER enzymes, pol b and APE1 in processing an
intermediate formed during active DNA demethylation and a BER intermediate
simultaneously in the context of CpGs and their effects on genome integrity. We found that
when the BER intermediate, abasic site (AP site) is generated next to the 5-methylcytosine
deamination product, a T/G mismatch, TDG failed to remove the mismatched T. Yet, the
abasic site could still be efficiently incised by APE1 leading to a 3'-mismatched T. We
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found that pol b efficiently extended the 3'-mismatched T resulting in the sustainment of a
C to T mutation. However, we found that high concentrations of APE1 3'-5' exonuclease
activity efficiently removed the mismatched T before pol β could extend the 3'-mismatched
T, thereby preventing the C to T mutation. We found that APE1 3'-5' exonuclease cleaved
the mismatched T 10-fold faster than pol b extended the 3'-mismatched T during BER.
Since the amount of APE1 is much more abundant than pol b in cells, the results indicated
that APE1 3'-5' exonuclease cooperated with pol β to serve as a proofreading factor of pol
β improving the fidelity of the polymerase during BER and preventing pol β-mediated
mutagenesis. In Chapter 3, we further explored how bromate and chromate-induced
oxidative DNA base lesions may modulate DNA methylation pattern at the tumor
suppressor, BRCA1 gene via BER. We found that bromate and chromate-induced oxidative
base lesions resulted in loss of 5mCs and mutations in the promoter and encoding regions
of BRCA1 gene in HEK293 cells. Surprisingly, we found that bromate and chromate also
induced additional DNA methylations at the CpGs adjacent to the CpGs bearing loss of
5mCs and mutations. Further mutational analysis on the mutation spectrum showed that
bromate and chromate predominantly resulted in C to G and C to A mutations at the CpGs
located at the BRCA1 gene promoter and encoding region. Furthermore, employing
immunofluorescence, we showed that bromate and chromate induced the formation of pol
β foci in the nucleus of HEK293 cells indicating that pol β was recruited to the DNA
damage sites induced by the DNA damaging agents. We further demonstrated that the C to
G and C to A mutations were mediated by pol β nucleotide misinsertion in bypassing an 8oxoG on the complementary strand of the gene.

Furthermore, employing co-

immunoprecipitation, we discovered an interaction between pol β and DNMT1 in HEK293
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cells upon bromate and chromate treatment. The results showed that pol β and DNMT1
interacted immediately after cells were treated with the DNA damaging agents. Yet, the
interaction disappeared after 24 h recovery from the DNA damaging agents. We suggest
that bromate and chromate-induced oxidative DNA damage recruited pol β which in turn
interacts and recruits DNMT1 to the sites adjacent to the DNA damage sites. This
subsequently may allow DNMT1 to create additional 5mCs at the CpGs located at BRCA1
gene promoter and encoding regions, thereby altering DNA methylation pattern of the
gene. Our results provide new insights into the mechanisms by which DNA base lesions
modulate epigenetic features via BER that plays a central role in mediating the interaction
between the human genome and epigenome.
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